Imported Disease Annotations - CTDTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | congenital disorder of glycosylation type IIm | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | | |
|
Imported Disease Annotations - CTDTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | congenital disorder of glycosylation type IIm | | EXP | | 11554173 | CTD Direct Evidence: marker/mechanism | CTD | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
# | Reference Title | Reference Citation |
1. | GOAs Human GO annotations | GOA_HUMAN data from the GO Consortium |
2. | OMIM Disease Annotation Pipeline | OMIM Disease Annotation Pipeline |
3. | ClinVar Automated Import and Annotation Pipeline | RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations |
4. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
5. | RGD HPO Phenotype Annotation Pipeline | RGD automated import pipeline for human HPO-to-gene-to-disease annotations |
PMID:3561849 | PMID:8125298 | PMID:8128316 | PMID:8889805 | PMID:9010752 | PMID:9399569 | PMID:11279205 | PMID:11389099 | PMID:12477932 | PMID:12925779 | PMID:14702039 | PMID:16189514 |
PMID:18029348 | PMID:18854154 | PMID:20301507 | PMID:21873635 | PMID:21918738 | PMID:22810586 | PMID:23089177 | PMID:23561849 | PMID:23583405 | PMID:24115232 | PMID:25416956 | PMID:25451267 |
PMID:25944901 | PMID:26472760 | PMID:27743886 | PMID:28167211 | PMID:28514442 | PMID:28692057 | PMID:28986522 | PMID:29679388 | PMID:29907092 | PMID:30194290 | PMID:30639242 | PMID:30746764 |
PMID:30817854 | PMID:32296183 | PMID:32605344 | PMID:32694731 | PMID:33407896 | PMID:33845483 | PMID:33961781 | PMID:34079125 | PMID:34161696 | PMID:34384782 | PMID:34432599 | PMID:35696571 |
PMID:35748872 | PMID:36307217 | PMID:36454514 | PMID:36543142 | PMID:36724073 | PMID:36933771 | PMID:37739137 | PMID:37774976 | PMID:38117590 | PMID:38143314 |
SLC35A2 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Slc35a2 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Slc35a2 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Slc35a2 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SLC35A2 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SLC35A2 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Slc35a2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SLC35A2 (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SLC35A2 (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Slc35a2 (Heterocephalus glaber - naked mole-rat) |
|
.
Variants in SLC35A2
263 total Variants |
Name | Type | Condition(s) | Position(s) | Clinical significance |
NM_005660.3(SLC35A2):c.958G>T (p.Val320Leu) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000554593] | ChrX:48904951 [GRCh38] ChrX:48762228 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.275-16TCC[2] | microsatellite | SLC35A2-congenital disorder of glycosylation [RCV000548567] | ChrX:48906551..48906553 [GRCh38] ChrX:48763828..48763830 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.942C>T (p.Arg314=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000542094] | ChrX:48904967 [GRCh38] ChrX:48762244 [GRCh37] ChrX:Xp11.23 |
likely benign |
SLC35A2:c.15_91+48delinsA | indel | SLC35A2-congenital disorder of glycosylation [RCV000043514] | ChrX:48911498..48911622 [GRCh38] ChrX:48768775..48768899 [GRCh37] ChrX:Xp11.23 |
pathogenic|other |
NM_005660.3(SLC35A2):c.991G>A (p.Val331Ile) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000043515]|not provided [RCV000498343] | ChrX:48904918 [GRCh38] ChrX:48762195 [GRCh37] ChrX:Xp11.23 |
pathogenic|likely pathogenic|other |
NM_005660.3(SLC35A2):c.3G>A (p.Met1Ile) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000043516] | ChrX:48911634 [GRCh38] ChrX:48768911 [GRCh37] ChrX:Xp11.23 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:3092486-155699618)x2 | copy number gain | See cases [RCV000050889] | ChrX:3092486..155699618 [GRCh38] ChrX:3010527..154929279 [GRCh37] ChrX:3020527..154582473 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:20140-155699618)x3 | copy number gain | See cases [RCV000050810] | ChrX:20140..155699618 [GRCh38] ChrX:70140..154929279 [GRCh37] ChrX:10140..154582473 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:20140-155699618)x1 | copy number loss | See cases [RCV000050811] | ChrX:20140..155699618 [GRCh38] ChrX:70140..154929279 [GRCh37] ChrX:10140..154582473 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:10679-156022206)x1 | copy number loss | See cases [RCV000050699] | ChrX:10679..156022206 [GRCh38] ChrX:60679..155251871 [GRCh37] ChrX:679..154905065 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic|conflicting interpretations of pathogenicity|conflicting data from submitters |
GRCh38/hg38 Xp22.33-q28(chrX:10679-156013167)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000050385]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000050385]|See cases [RCV000050385] | ChrX:10679..156013167 [GRCh38] ChrX:60679..155242832 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:10679-156013167)x1 | copy number loss | Global developmental delay [RCV000050386]|See cases [RCV000050386] | ChrX:10679..156013167 [GRCh38] ChrX:60679..155242832 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:10679-156022206)x3 | copy number gain | See cases [RCV000050697] | ChrX:10679..156022206 [GRCh38] ChrX:60679..155251871 [GRCh37] ChrX:679..154905065 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic|conflicting interpretations of pathogenicity|conflicting data from submitters |
GRCh38/hg38 Xp22.33-11.22(chrX:10679-52809182)x1 | copy number loss | See cases [RCV000051026] | ChrX:10679..52809182 [GRCh38] ChrX:60679..52838206 [GRCh37] ChrX:679..52854931 [NCBI36] ChrX:Xp22.33-11.22 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:26101-155999293)x3 | copy number gain | See cases [RCV000052322] | ChrX:26101..155999293 [GRCh38] ChrX:76101..155228958 [GRCh37] ChrX:16101..154882152 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:2790845-155699618)x3 | copy number gain | See cases [RCV000052359] | ChrX:2790845..155699618 [GRCh38] ChrX:2708886..154929279 [GRCh37] ChrX:2718886..154582473 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:237659-156022362)x3 | copy number gain | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052327]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052327]|See cases [RCV000052327] | ChrX:237659..156022362 [GRCh38] ChrX:154326..155252027 [GRCh37] ChrX:94326..154905221 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:27245-155996431)x3 | copy number gain | See cases [RCV000052324] | ChrX:27245..155996431 [GRCh38] ChrX:77245..155226096 [GRCh37] ChrX:17245..154879290 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:40704-156022362)x3 | copy number gain | See cases [RCV000052325] | ChrX:40704..156022362 [GRCh38] ChrX:90704..155252027 [GRCh37] ChrX:30704..154905221 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp11.23-11.22(chrX:47859417-52789530)x3 | copy number gain | See cases [RCV000052390] | ChrX:47859417..52789530 [GRCh38] ChrX:47835880..52818575 [GRCh37] ChrX:47603760..52835300 [NCBI36] ChrX:Xp11.23-11.22 |
pathogenic |
GRCh38/hg38 Xp11.23-11.22(chrX:48344666-52664916)x2 | copy number gain | See cases [RCV000051992] | ChrX:48344666..52664916 [GRCh38] ChrX:48204101..52616581 [GRCh37] ChrX:48089045..52710691 [NCBI36] ChrX:Xp11.23-11.22 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:26102-155996431)x1 | copy number loss | Global developmental delay [RCV000052986]|Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052987]|Intellectual functioning disability [RCV000052988]|Global developmental delay [RCV000052989]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052987]|See cases [RCV000052986] | ChrX:26102..155996431 [GRCh38] ChrX:76102..155226096 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q22.1(chrX:675360-100368517)x1 | copy number loss | See cases [RCV000053005] | ChrX:675360..100368517 [GRCh38] ChrX:636095..99623515 [GRCh37] ChrX:556095..99510171 [NCBI36] ChrX:Xp22.33-q22.1 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:14245-155999293)x1 | copy number loss | Hypoplastic left heart [RCV000052982]|See cases [RCV000052982] | ChrX:14245..155999293 [GRCh38] ChrX:64245..155228958 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-11.21(chrX:2769041-58055036)x1 | copy number loss | See cases [RCV000053007] | ChrX:2769041..58055036 [GRCh38] ChrX:2687082..58081470 [GRCh37] ChrX:2697082..58098195 [NCBI36] ChrX:Xp22.33-11.21 |
pathogenic |
GRCh38/hg38 Xp22.33-11.21(chrX:26102-57302794)x1 | copy number loss | See cases [RCV000052990] | ChrX:26102..57302794 [GRCh38] ChrX:76102..57329227 [GRCh37] ChrX:16102..57345952 [NCBI36] ChrX:Xp22.33-11.21 |
pathogenic |
GRCh38/hg38 Xp22.33-11.1(chrX:253129-58271563)x1 | copy number loss | See cases [RCV000052994] | ChrX:253129..58271563 [GRCh38] ChrX:169796..58297997 [GRCh37] ChrX:109796..58314722 [NCBI36] ChrX:Xp22.33-11.1 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:26102-155996431)x3 | copy number gain | Global developmental delay [RCV000052984]|Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052985]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052985]|See cases [RCV000052984] | ChrX:26102..155996431 [GRCh38] ChrX:76102..155226096 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-11.21(chrX:10679-55550898)x1 | copy number loss | Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052971]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052971]|See cases [RCV000052971] | ChrX:10679..55550898 [GRCh38] ChrX:60679..55577331 [GRCh37] ChrX:679..55594056 [NCBI36] ChrX:Xp22.33-11.21 |
pathogenic |
GRCh38/hg38 Xp11.23(chrX:48612125-49292405)x2 | copy number gain | See cases [RCV000054185] | ChrX:48612125..49292405 [GRCh38] ChrX:48510591..49148873 [GRCh37] ChrX:48355457..49035817 [NCBI36] ChrX:Xp11.23 |
uncertain significance |
GRCh38/hg38 Xp22.33-11.22(chrX:10479-54179172)x3 | copy number gain | See cases [RCV000053817] | ChrX:10479..54179172 [GRCh38] ChrX:60479..53957191 [GRCh37] ChrX:479..54222330 [NCBI36] ChrX:Xp22.33-11.22 |
pathogenic |
NM_006875.3(PIM2):c.651C>T (p.Leu217=) | single nucleotide variant | Malignant melanoma [RCV000073207] | ChrX:48914516 [GRCh38] ChrX:48771793 [GRCh37] ChrX:48656737 [NCBI36] ChrX:Xp11.23 |
not provided |
NM_005660.3(SLC35A2):c.433_434del (p.Tyr145fs) | deletion | SLC35A2-congenital disorder of glycosylation [RCV000122744] | ChrX:48905475..48905476 [GRCh38] ChrX:48762752..48762753 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.972del (p.Phe324fs) | deletion | SLC35A2-congenital disorder of glycosylation [RCV000122745] | ChrX:48904937 [GRCh38] ChrX:48762214 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.638C>T (p.Ser213Phe) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000122746] | ChrX:48905271 [GRCh38] ChrX:48762548 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_001282648.2(SLC35A2):c.-81_202+1del | deletion | SLC35A2-congenital disorder of glycosylation [RCV001374457] | ChrX:48909813..48911958 [GRCh38] ChrX:48767090..48769235 [GRCh37] ChrX:Xp11.23 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:10679-156022826)x4 | copy number gain | See cases [RCV000133654] | ChrX:10679..156022826 [GRCh38] ChrX:60679..155252491 [GRCh37] ChrX:679..154905685 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-11.21(chrX:70297-58066465)x3 | copy number gain | See cases [RCV000239834] | ChrX:70297..58066465 [GRCh37] ChrX:Xp22.33-11.21 |
pathogenic |
GRCh38/hg38 Xp22.33-11.22(chrX:10701-52857805)x1 | copy number loss | See cases [RCV000133817] | ChrX:10701..52857805 [GRCh38] ChrX:60701..52886834 [GRCh37] ChrX:701..52903559 [NCBI36] ChrX:Xp22.33-11.22 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:10701-155978689)x1 | copy number loss | See cases [RCV000133792] | ChrX:10701..155978689 [GRCh38] ChrX:60701..155208354 [GRCh37] ChrX:701..154861548 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:10679-156013167)x3 | copy number gain | See cases [RCV000050385] | ChrX:10679..156013167 [GRCh38] ChrX:60679..155242832 [GRCh37] ChrX:679..154896026 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:10679-156013167)x1 | copy number loss | See cases [RCV000050386] | ChrX:10679..156013167 [GRCh38] ChrX:60679..155242832 [GRCh37] ChrX:679..154896026 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:14245-155999293)x1 | copy number loss | See cases [RCV000052982] | ChrX:14245..155999293 [GRCh38] ChrX:64245..155228958 [GRCh37] ChrX:4245..154882152 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:26102-155996431)x3 | copy number gain | See cases [RCV000052984] | ChrX:26102..155996431 [GRCh38] ChrX:76102..155226096 [GRCh37] ChrX:16102..154879290 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:26102-155996431)x1 | copy number loss | See cases [RCV000052986] | ChrX:26102..155996431 [GRCh38] ChrX:76102..155226096 [GRCh37] ChrX:16102..154879290 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-11.23(chrX:10679-50059388)x1 | copy number loss | See cases [RCV000133745] | ChrX:10679..50059388 [GRCh38] ChrX:60679..49824045 [GRCh37] ChrX:679..49710785 [NCBI36] ChrX:Xp22.33-11.23 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:20297-155999253)x3 | copy number gain | See cases [RCV000134564] | ChrX:20297..155999253 [GRCh38] ChrX:70297..155228918 [GRCh37] ChrX:10297..154882112 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q11.1(chrX:10701-62712219)x1 | copy number loss | See cases [RCV000134568] | ChrX:10701..62712219 [GRCh38] ChrX:60701..61931689 [GRCh37] ChrX:701..61848414 [NCBI36] ChrX:Xp22.33-q11.1 |
pathogenic |
GRCh38/hg38 Xp22.33-11.21(chrX:10701-58055053)x1 | copy number loss | See cases [RCV000134026] | ChrX:10701..58055053 [GRCh38] ChrX:60701..58081487 [GRCh37] ChrX:701..58098212 [NCBI36] ChrX:Xp22.33-11.21 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:10701-156003242)x1 | copy number loss | See cases [RCV000133947] | ChrX:10701..156003242 [GRCh38] ChrX:60701..155232907 [GRCh37] ChrX:701..154886101 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic|conflicting interpretations of pathogenicity|conflicting data from submitters |
GRCh38/hg38 Xp22.33-q28(chrX:10701-156003242)x3 | copy number gain | See cases [RCV000133911] | ChrX:10701..156003242 [GRCh38] ChrX:60701..155232907 [GRCh37] ChrX:701..154886101 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic|likely pathogenic|conflicting data from submitters |
GRCh38/hg38 Xp21.1-q28(chrX:37076284-156016920)x1 | copy number loss | See cases [RCV000135300] | ChrX:37076284..156016920 [GRCh38] ChrX:37094357..155246585 [GRCh37] ChrX:37004278..154899779 [NCBI36] ChrX:Xp21.1-q28 |
pathogenic |
GRCh38/hg38 Xp22.31-11.22(chrX:8176030-53962833)x1 | copy number loss | See cases [RCV000135305] | ChrX:8176030..53962833 [GRCh38] ChrX:8144071..53989266 [GRCh37] ChrX:8104071..54005991 [NCBI36] ChrX:Xp22.31-11.22 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:20297-156026127)x1 | copy number loss | See cases [RCV000135321] | ChrX:20297..156026127 [GRCh38] ChrX:70297..155255792 [GRCh37] ChrX:10297..154908986 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp11.3-11.22(chrX:43361870-50931794)x3 | copy number gain | See cases [RCV000134956] | ChrX:43361870..50931794 [GRCh38] ChrX:43221119..50674794 [GRCh37] ChrX:43106063..50691534 [NCBI36] ChrX:Xp11.3-11.22 |
pathogenic |
GRCh38/hg38 Xp22.33-11.22(chrX:10679-52857805)x3 | copy number gain | See cases [RCV000134957] | ChrX:10679..52857805 [GRCh38] ChrX:60679..52886834 [GRCh37] ChrX:679..52903559 [NCBI36] ChrX:Xp22.33-11.22 |
pathogenic |
GRCh38/hg38 Xp11.23-11.22(chrX:48022053-52664916)x3 | copy number gain | See cases [RCV000135801] | ChrX:48022053..52664916 [GRCh38] ChrX:47881447..52616581 [GRCh37] ChrX:47766391..52710691 [NCBI36] ChrX:Xp11.23-11.22 |
pathogenic|uncertain significance |
GRCh38/hg38 Xp21.1-q28(chrX:36237706-156022206)x1 | copy number loss | See cases [RCV000135552] | ChrX:36237706..156022206 [GRCh38] ChrX:36255823..155251871 [GRCh37] ChrX:36165744..154905065 [NCBI36] ChrX:Xp21.1-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:10701-156003229)x1 | copy number loss | See cases [RCV000136097] | ChrX:10701..156003229 [GRCh38] ChrX:60701..155232894 [GRCh37] ChrX:701..154886088 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:40904-155998166)x1 | copy number loss | See cases [RCV000136478] | ChrX:40904..155998166 [GRCh38] ChrX:90904..155227831 [GRCh37] ChrX:30904..154881025 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q25(chrX:10701-128393708) | copy number loss | See cases [RCV000136094] | ChrX:10701..128393708 [GRCh38] ChrX:60701..127527686 [GRCh37] ChrX:701..127355367 [NCBI36] ChrX:Xp22.33-q25 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:10001-156030895)x1 | copy number loss | See cases [RCV000136005] | ChrX:10001..156030895 [GRCh38] ChrX:60001..155260560 [GRCh37] ChrX:1..154913754 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp11.23-11.21(chrX:48344666-58055036)x3 | copy number gain | See cases [RCV000135958] | ChrX:48344666..58055036 [GRCh38] ChrX:48204101..58081470 [GRCh37] ChrX:48089045..58098195 [NCBI36] ChrX:Xp11.23-11.21 |
pathogenic |
GRCh38/hg38 Xp22.33-q13.3(chrX:10679-76420505)x3 | copy number gain | See cases [RCV000137137] | ChrX:10679..76420505 [GRCh38] ChrX:60679..75640898 [GRCh37] ChrX:679..75557302 [NCBI36] ChrX:Xp22.33-q13.3 |
pathogenic|likely benign |
GRCh38/hg38 Xp22.33-11.22(chrX:10679-52213731)x1 | copy number loss | See cases [RCV000137112] | ChrX:10679..52213731 [GRCh38] ChrX:60679..51948998 [GRCh37] ChrX:679..51973598 [NCBI36] ChrX:Xp22.33-11.22 |
pathogenic|uncertain significance |
GRCh38/hg38 Xp22.33-q28(chrX:2782275-155611794)x2 | copy number gain | See cases [RCV000136841] | ChrX:2782275..155611794 [GRCh38] ChrX:2700316..154785891 [GRCh37] ChrX:2710316..154494649 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:2765636-155522304)x3 | copy number gain | See cases [RCV000136791] | ChrX:2765636..155522304 [GRCh38] ChrX:2683677..154751965 [GRCh37] ChrX:2693677..154405159 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp11.23-11.22(chrX:48260861-52664916)x2 | copy number gain | See cases [RCV000136829] | ChrX:48260861..52664916 [GRCh38] ChrX:48120296..52616581 [GRCh37] ChrX:48005240..52710691 [NCBI36] ChrX:Xp11.23-11.22 |
pathogenic |
GRCh38/hg38 Xp22.33-11.22(chrX:10701-52033734)x1 | copy number loss | See cases [RCV000137430] | ChrX:10701..52033734 [GRCh38] ChrX:60701..51776830 [GRCh37] ChrX:701..51793570 [NCBI36] ChrX:Xp22.33-11.22 |
pathogenic |
GRCh38/hg38 Xp22.33-11.21(chrX:10701-58055036)x1 | copy number loss | See cases [RCV000137552] | ChrX:10701..58055036 [GRCh38] ChrX:60701..58081470 [GRCh37] ChrX:701..58098195 [NCBI36] ChrX:Xp22.33-11.21 |
pathogenic |
GRCh38/hg38 Xp22.33-11.23(chrX:10679-49157514)x1 | copy number loss | See cases [RCV000137166] | ChrX:10679..49157514 [GRCh38] ChrX:60679..49016667 [GRCh37] ChrX:679..48903611 [NCBI36] ChrX:Xp22.33-11.23 |
pathogenic |
GRCh38/hg38 Xp22.33-11.23(chrX:10701-49071220)x1 | copy number loss | See cases [RCV000137413] | ChrX:10701..49071220 [GRCh38] ChrX:60701..48928877 [GRCh37] ChrX:701..48815821 [NCBI36] ChrX:Xp22.33-11.23 |
pathogenic |
GRCh38/hg38 Xp11.3-11.23(chrX:44765664-49343053)x3 | copy number gain | See cases [RCV000137271] | ChrX:44765664..49343053 [GRCh38] ChrX:44624910..49218180 [GRCh37] ChrX:44509854..49105124 [NCBI36] ChrX:Xp11.3-11.23 |
likely pathogenic |
GRCh38/hg38 Xp11.23-11.22(chrX:48429509-52664916)x3 | copy number gain | See cases [RCV000138106] | ChrX:48429509..52664916 [GRCh38] ChrX:48287896..52616581 [GRCh37] ChrX:48172840..52710691 [NCBI36] ChrX:Xp11.23-11.22 |
pathogenic|likely pathogenic |
GRCh38/hg38 Xp11.23-11.22(chrX:48429509-52664916)x1 | copy number loss | See cases [RCV000138107] | ChrX:48429509..52664916 [GRCh38] ChrX:48287896..52693966 [GRCh37] ChrX:48172840..52710691 [NCBI36] ChrX:Xp11.23-11.22 |
pathogenic |
GRCh38/hg38 Xp22.33-q22.3(chrX:10701-106113403)x1 | copy number loss | See cases [RCV000137886] | ChrX:10701..106113403 [GRCh38] ChrX:60701..105357395 [GRCh37] ChrX:701..105244051 [NCBI36] ChrX:Xp22.33-q22.3 |
pathogenic |
GRCh38/hg38 Xp22.2-q27.3(chrX:13020141-143473520)x1 | copy number loss | See cases [RCV000138678] | ChrX:13020141..143473520 [GRCh38] ChrX:13038260..142561303 [GRCh37] ChrX:12948181..142388969 [NCBI36] ChrX:Xp22.2-q27.3 |
pathogenic |
GRCh38/hg38 Xp22.33-11.1(chrX:10701-58517661)x1 | copy number loss | See cases [RCV000139343] | ChrX:10701..58517661 [GRCh38] ChrX:60701..58544094 [GRCh37] ChrX:701..58560819 [NCBI36] ChrX:Xp22.33-11.1 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:1085618-155699644)x1 | copy number loss | See cases [RCV000139278] | ChrX:1085618..155699644 [GRCh38] ChrX:1118268..154929305 [GRCh37] ChrX:1038268..154582499 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q21.31(chrX:10701-88318651)x1 | copy number loss | See cases [RCV000139352] | ChrX:10701..88318651 [GRCh38] ChrX:60701..87573652 [GRCh37] ChrX:701..87460308 [NCBI36] ChrX:Xp22.33-q21.31 |
pathogenic |
GRCh38/hg38 Xp11.23-11.22(chrX:48386298-52664916)x2 | copy number gain | See cases [RCV000139185] | ChrX:48386298..52664916 [GRCh38] ChrX:48245740..52616581 [GRCh37] ChrX:48130684..52710691 [NCBI36] ChrX:Xp11.23-11.22 |
pathogenic|uncertain significance |
GRCh38/hg38 Xp22.33-q28(chrX:251880-156004181)x3 | copy number gain | See cases [RCV000139888] | ChrX:251880..156004181 [GRCh38] ChrX:168547..155233846 [GRCh37] ChrX:108547..154887040 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:2299223-155992188)x3 | copy number gain | See cases [RCV000141400] | ChrX:2299223..155992188 [GRCh38] ChrX:2217264..155221853 [GRCh37] ChrX:2227264..154875047 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:20297-156016920)x3 | copy number gain | See cases [RCV000141401] | ChrX:20297..156016920 [GRCh38] ChrX:70297..155246585 [GRCh37] ChrX:10297..154899779 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:251880-156004066)x4 | copy number gain | See cases [RCV000140786] | ChrX:251880..156004066 [GRCh38] ChrX:168547..155233731 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-11.22(chrX:10701-53750424)x1 | copy number loss | See cases [RCV000140711] | ChrX:10701..53750424 [GRCh38] ChrX:60701..53776922 [GRCh37] ChrX:701..53793647 [NCBI36] ChrX:Xp22.33-11.22 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:251880-156004066)x1 | copy number loss | See cases [RCV000140787] | ChrX:251880..156004066 [GRCh38] ChrX:168547..155233731 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic|conflicting data from submitters |
GRCh38/hg38 Xp22.33-11.22(chrX:251879-50289363)x1 | copy number loss | See cases [RCV000141741] | ChrX:251879..50289363 [GRCh38] ChrX:168546..50032363 [GRCh37] ChrX:108546..50049103 [NCBI36] ChrX:Xp22.33-11.22 |
pathogenic |
GRCh38/hg38 Xp11.3-11.22(chrX:46971389-54130971)x3 | copy number gain | See cases [RCV000141567] | ChrX:46971389..54130971 [GRCh38] ChrX:46818746..53957191 [GRCh37] ChrX:46703690..54174129 [NCBI36] ChrX:Xp11.3-11.22 |
pathogenic |
GRCh38/hg38 Xp22.33-q12(chrX:251880-66445845)x1 | copy number loss | See cases [RCV000142334] | ChrX:251880..66445845 [GRCh38] ChrX:168547..65665687 [GRCh37] ChrX:108547..65582412 [NCBI36] ChrX:Xp22.33-q12 |
pathogenic |
GRCh38/hg38 Xp22.33-11.22(chrX:251880-51643625)x1 | copy number loss | See cases [RCV000142035] | ChrX:251880..51643625 [GRCh38] ChrX:168547..51386559 [GRCh37] ChrX:108547..51403299 [NCBI36] ChrX:Xp22.33-11.22 |
pathogenic |
GRCh38/hg38 Xp22.33-q24(chrX:251879-118847157)x3 | copy number gain | See cases [RCV000142134] | ChrX:251879..118847157 [GRCh38] ChrX:168546..117981120 [GRCh37] ChrX:108546..117865148 [NCBI36] ChrX:Xp22.33-q24 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:10701-156003229)x3 | copy number gain | See cases [RCV000142625] | ChrX:10701..156003229 [GRCh38] ChrX:60701..155232894 [GRCh37] ChrX:701..154886088 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:251879-156004066)x1 | copy number loss | See cases [RCV000143441] | ChrX:251879..156004066 [GRCh38] ChrX:168546..155233731 [GRCh37] ChrX:108546..154886925 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:251879-156004066)x3 | copy number gain | See cases [RCV000143433] | ChrX:251879..156004066 [GRCh38] ChrX:168546..155233731 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-11.22(chrX:10701-53131191)x1 | copy number loss | See cases [RCV000143348] | ChrX:10701..53131191 [GRCh38] ChrX:60701..53047381 [GRCh37] ChrX:701..53177098 [NCBI36] ChrX:Xp22.33-11.22 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:251880-156004066)x3 | copy number gain | See cases [RCV000143219] | ChrX:251880..156004066 [GRCh38] ChrX:168547..155233731 [GRCh37] ChrX:108547..154886925 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-11.21(chrX:251879-56428859)x1 | copy number loss | See cases [RCV000143130] | ChrX:251879..56428859 [GRCh38] ChrX:168546..56455292 [GRCh37] ChrX:108546..56472017 [NCBI36] ChrX:Xp22.33-11.21 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:10679-156022206)x3 | copy number gain | See cases [RCV000148141] | ChrX:10679..156022206 [GRCh38] ChrX:60679..155251871 [GRCh37] ChrX:679..154905065 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh38/hg38 Xp22.33-q28(chrX:10679-156022206)x1 | copy number loss | See cases [RCV000148135] | ChrX:10679..156022206 [GRCh38] ChrX:60679..155251871 [GRCh37] ChrX:679..154905065 [NCBI36] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:71267-155246643)x3 | copy number gain | See cases [RCV000240122] | ChrX:71267..155246643 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:176426-155250222)x3 | copy number gain | See cases [RCV000239843] | ChrX:176426..155250222 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.2-q28(chrX:13147668-155250222)x3 | copy number gain | See cases [RCV000239798] | ChrX:13147668..155250222 [GRCh37] ChrX:Xp22.2-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-11.21(chrX:70297-58066465)x1 | copy number loss | See cases [RCV000239814] | ChrX:70297..58066465 [GRCh37] ChrX:Xp22.33-11.21 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:71267-155255839)x1 | copy number loss | See cases [RCV000239832] | ChrX:71267..155255839 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp11.23-11.22(chrX:48310313-52614698)x1 | copy number loss | See cases [RCV000203435] | ChrX:48310313..52614698 [GRCh37] ChrX:Xp11.23-11.22 |
pathogenic|uncertain significance |
NM_005660.3(SLC35A2):c.800A>G (p.Tyr267Cys) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000210405] | ChrX:48905109 [GRCh38] ChrX:48762386 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
NM_005660.3(SLC35A2):c.747G>A (p.Gly249=) | single nucleotide variant | Inborn genetic diseases [RCV002390609]|SLC35A2-congenital disorder of glycosylation [RCV000229740] | ChrX:48905162 [GRCh38] ChrX:48762439 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.12T>G (p.Val4=) | single nucleotide variant | Inborn genetic diseases [RCV002317759]|SLC35A2-congenital disorder of glycosylation [RCV000225834]|not provided [RCV002274942] | ChrX:48911625 [GRCh38] ChrX:48768902 [GRCh37] ChrX:Xp11.23 |
benign|likely benign |
GRCh37/hg19 Xp22.33-q28(chrX:70297-155255839)x3 | copy number gain | See cases [RCV000239934] | ChrX:70297..155255839 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:150002-155234036)x2 | copy number gain | See cases [RCV000240106] | ChrX:150002..155234036 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:71267-155224766)x1 | copy number loss | See cases [RCV000239902] | ChrX:71267..155224766 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:60701-155246271)x3 | copy number gain | See cases [RCV000239989] | ChrX:60701..155246271 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:553069-155233731)x1 | copy number loss | See cases [RCV000446026] | ChrX:553069..155233731 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp11.3-q21.1(chrX:44734936-79676121)x3 | copy number gain | See cases [RCV000240019] | ChrX:44734936..79676121 [GRCh37] ChrX:Xp11.3-q21.1 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:71267-155234036)x2 | copy number gain | See cases [RCV000239874] | ChrX:71267..155234036 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:225816-155234036)x2 | copy number gain | See cases [RCV000240464] | ChrX:225816..155234036 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:176426-155236656)x3 | copy number gain | See cases [RCV000240552] | ChrX:176426..155236656 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:150002-155234036)x3 | copy number gain | See cases [RCV000240314] | ChrX:150002..155234036 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:2707626-155250222)x2 | copy number gain | See cases [RCV000240541] | ChrX:2707626..155250222 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
NM_005660.3(SLC35A2):c.826C>T (p.Leu276Phe) | single nucleotide variant | Inborn genetic diseases [RCV002429215]|SLC35A2-congenital disorder of glycosylation [RCV002521886]|not provided [RCV000377201] | ChrX:48905083 [GRCh38] ChrX:48762360 [GRCh37] ChrX:Xp11.23 |
benign|uncertain significance |
GRCh37/hg19 Xp22.2-q25(chrX:11692290-121187337)x2 | copy number gain | not provided [RCV000488046] | ChrX:11692290..121187337 [GRCh37] ChrX:Xp22.2-q25 |
uncertain significance |
NM_005660.3(SLC35A2):c.1066_1067insGCCTCT (p.Ala355_Ser356insCysLeu) | microsatellite | Developmental and epileptic encephalopathy, 1 [RCV000626159] | ChrX:48904842..48904843 [GRCh38] ChrX:48762119..48762120 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.795del (p.Phe265fs) | deletion | Inborn genetic diseases [RCV000624242] | ChrX:48905114 [GRCh38] ChrX:48762391 [GRCh37] ChrX:Xp11.23 |
pathogenic |
Single allele | duplication | Syndromic X-linked intellectual disability Lubs type [RCV000768455] | ChrX:15323210..153542100 [GRCh37] ChrX:Xp22.2-q28 |
pathogenic |
NM_005660.3(SLC35A2):c.500_509del (p.Leu167fs) | deletion | Epileptic encephalopathy [RCV000415123] | ChrX:48905400..48905409 [GRCh38] ChrX:48762677..48762686 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
NM_005660.3(SLC35A2):c.617_620del (p.Val206fs) | deletion | SLC35A2-congenital disorder of glycosylation [RCV000415221] | ChrX:48905289..48905292 [GRCh38] ChrX:48762566..48762569 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.245G>T (p.Cys82Phe) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000560194] | ChrX:48909843 [GRCh38] ChrX:48767120 [GRCh37] ChrX:Xp11.23 |
likely pathogenic|uncertain significance |
NM_005660.3(SLC35A2):c.102C>T (p.Arg34=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001455458] | ChrX:48909986 [GRCh38] ChrX:48767263 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.634TCC[1] (p.Ser213del) | microsatellite | not provided [RCV000414069] | ChrX:48905270..48905272 [GRCh38] ChrX:48762547..48762549 [GRCh37] ChrX:Xp11.23 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:168546-154930047)x3 | copy number gain | See cases [RCV000449437] | ChrX:168546..154930047 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:168546-155233731)x3 | copy number gain | See cases [RCV000449330] | ChrX:168546..155233731 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:70297-155255792) | copy number loss | See cases [RCV000449461] | ChrX:70297..155255792 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp11.23-11.22(chrX:48317353-51497588)x3 | copy number gain | See cases [RCV000449147] | ChrX:48317353..51497588 [GRCh37] ChrX:Xp11.23-11.22 |
pathogenic |
GRCh37/hg19 Xp22.33-11.21(chrX:168546-55529093)x1 | copy number loss | See cases [RCV000446584] | ChrX:168546..55529093 [GRCh37] ChrX:Xp22.33-11.21 |
pathogenic |
GRCh37/hg19 Xp22.33-11.21(chrX:168546-56684082)x1 | copy number loss | See cases [RCV000447092] | ChrX:168546..56684082 [GRCh37] ChrX:Xp22.33-11.21 |
pathogenic |
GRCh37/hg19 Xp22.33-11.22(chrX:168546-52573789)x1 | copy number loss | See cases [RCV000447470] | ChrX:168546..52573789 [GRCh37] ChrX:Xp22.33-11.22 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:2703632-155233731)x1 | copy number loss | See cases [RCV000446712] | ChrX:2703632..155233731 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:71267-155255792)x1 | copy number loss | See cases [RCV000446197] | ChrX:71267..155255792 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:60701-155246225)x3 | copy number gain | See cases [RCV000446270] | ChrX:60701..155246225 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:318707-155224707)x1 | copy number loss | See cases [RCV000446667] | ChrX:318707..155224707 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp11.23-11.22(chrX:48317353-51497588)x2 | copy number gain | See cases [RCV000447617] | ChrX:48317353..51497588 [GRCh37] ChrX:Xp11.23-11.22 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:168546-155233731)x4 | copy number gain | See cases [RCV000446932] | ChrX:168546..155233731 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:168546-155196888)x3 | copy number gain | See cases [RCV000446310] | ChrX:168546..155196888 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:168546-155081533)x3 | copy number gain | See cases [RCV000447253] | ChrX:168546..155081533 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
NM_005660.3(SLC35A2):c.236G>T (p.Gly79Val) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000536070]|not provided [RCV000423604] | ChrX:48909852 [GRCh38] ChrX:48767129 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.93T>C (p.Ala31=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003741215]|not provided [RCV000713316] | ChrX:48909995 [GRCh38] ChrX:48767272 [GRCh37] ChrX:Xp11.23 |
likely benign|uncertain significance |
NM_005660.3(SLC35A2):c.561C>T (p.Ala187=) | single nucleotide variant | Inborn genetic diseases [RCV002318428]|SLC35A2-congenital disorder of glycosylation [RCV000651308]|not specified [RCV000427885] | ChrX:48905348 [GRCh38] ChrX:48762625 [GRCh37] ChrX:Xp11.23 |
benign|likely benign |
NM_005660.3(SLC35A2):c.-8A>G | single nucleotide variant | not specified [RCV000431748] | ChrX:48911644 [GRCh38] ChrX:48768921 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.43C>A (p.Pro15Thr) | single nucleotide variant | Inborn genetic diseases [RCV002311462]|SLC35A2-congenital disorder of glycosylation [RCV000466900]|not provided [RCV000713315]|not specified [RCV000438491] | ChrX:48911594 [GRCh38] ChrX:48768871 [GRCh37] ChrX:Xp11.23 |
benign |
GRCh37/hg19 Xp22.33-q28(chrX:168566-155233731)x1 | copy number loss | See cases [RCV000445720] | ChrX:168566..155233731 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
NM_005660.3(SLC35A2):c.90G>C (p.Ala30=) | single nucleotide variant | Inborn genetic diseases [RCV002374674]|SLC35A2-congenital disorder of glycosylation [RCV001347966]|not specified [RCV000421392] | ChrX:48911547 [GRCh38] ChrX:48768824 [GRCh37] ChrX:Xp11.23 |
benign|likely benign|uncertain significance |
NM_005660.3(SLC35A2):c.594C>T (p.Asn198=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001461606]|not provided [RCV000864803] | ChrX:48905315 [GRCh38] ChrX:48762592 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1A>G (p.Met1Val) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002286410]|not provided [RCV000427117] | ChrX:48911636 [GRCh38] ChrX:48768913 [GRCh37] ChrX:Xp11.23 |
pathogenic|likely pathogenic |
NM_005660.3(SLC35A2):c.990C>T (p.Leu330=) | single nucleotide variant | Inborn genetic diseases [RCV002318423]|SLC35A2-congenital disorder of glycosylation [RCV000473172]|not specified [RCV000429903] | ChrX:48904919 [GRCh38] ChrX:48762196 [GRCh37] ChrX:Xp11.23 |
benign|likely benign |
GRCh37/hg19 Xp22.33-q28(chrX:168546-155233731)x1 | copy number loss | See cases [RCV000448393] | ChrX:168546..155233731 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:70297-155255792)x4 | copy number gain | See cases [RCV000448034] | ChrX:70297..155255792 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-11.1(chrX:168546-58140271)x1 | copy number loss | See cases [RCV000447773] | ChrX:168546..58140271 [GRCh37] ChrX:Xp22.33-11.1 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:70297-155246585)x1 | copy number loss | See cases [RCV000448652] | ChrX:70297..155246585 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-11.21(chrX:168546-55240087)x1 | copy number loss | See cases [RCV000512136] | ChrX:168546..55240087 [GRCh37] ChrX:Xp22.33-11.21 |
pathogenic |
NM_005660.3(SLC35A2):c.1058CCTCCG[1] (p.349AS[3]) | microsatellite | SLC35A2-congenital disorder of glycosylation [RCV000470970]|not specified [RCV000614805] | ChrX:48904840..48904845 [GRCh38] ChrX:48762117..48762122 [GRCh37] ChrX:Xp11.23 |
benign|likely benign|uncertain significance |
NM_005660.3(SLC35A2):c.535G>A (p.Val179Ile) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000456681] | ChrX:48905374 [GRCh38] ChrX:48762651 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.1163+44_1163+47del | deletion | not specified [RCV000487309] | ChrX:48904699..48904702 [GRCh38] ChrX:48761976..48761979 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.274+5G>A | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000466018]|not provided [RCV000578787] | ChrX:48909809 [GRCh38] ChrX:48767086 [GRCh37] ChrX:Xp11.23 |
likely benign|uncertain significance |
NM_005660.3(SLC35A2):c.426+287_775del | deletion | SLC35A2-congenital disorder of glycosylation [RCV000469944] | ChrX:48905134..48906105 [GRCh38] ChrX:48762411..48763382 [GRCh37] ChrX:Xp11.23 |
pathogenic |
GRCh37/hg19 Xp22.33-11.1(chrX:168546-58527164)x1 | copy number loss | See cases [RCV000510437] | ChrX:168546..58527164 [GRCh37] ChrX:Xp22.33-11.1 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:168547-151304063)x1 | copy number loss | See cases [RCV000510382] | ChrX:168547..151304063 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q23(chrX:168547-112474026)x1 | copy number loss | See cases [RCV000510419] | ChrX:168547..112474026 [GRCh37] ChrX:Xp22.33-q23 |
pathogenic |
GRCh37/hg19 Xp22.33-11.21(chrX:168546-57504183)x1 | copy number loss | See cases [RCV000511615] | ChrX:168546..57504183 [GRCh37] ChrX:Xp22.33-11.21 |
pathogenic |
NM_005660.3(SLC35A2):c.944T>C (p.Leu315Pro) | single nucleotide variant | not provided [RCV000493854] | ChrX:48904965 [GRCh38] ChrX:48762242 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
GRCh37/hg19 Xp22.33-11.21(chrX:168546-57683964)x1 | copy number loss | See cases [RCV000512022] | ChrX:168546..57683964 [GRCh37] ChrX:Xp22.33-11.21 |
pathogenic |
GRCh37/hg19 Xp21.1-q22.1(chrX:37521774-98488534)x1 | copy number loss | See cases [RCV000512026] | ChrX:37521774..98488534 [GRCh37] ChrX:Xp21.1-q22.1 |
pathogenic |
GRCh37/hg19 Xp21.2-q28(chrX:31088082-155233731)x1 | copy number loss | See cases [RCV000511413] | ChrX:31088082..155233731 [GRCh37] ChrX:Xp21.2-q28 |
pathogenic|uncertain significance |
GRCh37/hg19 Xp22.33-q28(chrX:168547-155233731) | copy number gain | See cases [RCV000512020] | ChrX:168547..155233731 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp11.3-11.23(chrX:46326268-48801984)x2 | copy number gain | See cases [RCV000511234] | ChrX:46326268..48801984 [GRCh37] ChrX:Xp11.3-11.23 |
likely pathogenic |
NM_005660.3(SLC35A2):c.346G>C (p.Ala116Pro) | single nucleotide variant | not provided [RCV000523416] | ChrX:48906472 [GRCh38] ChrX:48763749 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
GRCh37/hg19 Xp22.33-11.21(chrX:168546-54996659)x1 | copy number loss | See cases [RCV000510822] | ChrX:168546..54996659 [GRCh37] ChrX:Xp22.33-11.21 |
pathogenic |
NM_005660.3(SLC35A2):c.233A>G (p.Lys78Arg) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000766228] | ChrX:48909855 [GRCh38] ChrX:48767132 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.30C>G (p.Thr10=) | single nucleotide variant | Inborn genetic diseases [RCV002324046]|SLC35A2-congenital disorder of glycosylation [RCV000524549]|SLC35A2-related condition [RCV003905442]|not provided [RCV001568926]|not specified [RCV001288423] | ChrX:48911607 [GRCh38] ChrX:48768884 [GRCh37] ChrX:Xp11.23 |
benign|likely benign |
NM_005660.3(SLC35A2):c.447C>A (p.Ile149=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001421492]|not provided [RCV000863765]|not specified [RCV000613885] | ChrX:48905462 [GRCh38] ChrX:48762739 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_001042498.2(SLC35A2):c.-19G>A | single nucleotide variant | not specified [RCV000608616] | ChrX:48911655 [GRCh38] ChrX:48768932 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1062C>T (p.Ser354=) | single nucleotide variant | Inborn genetic diseases [RCV002413706]|SLC35A2-congenital disorder of glycosylation [RCV000885007]|not provided [RCV002063005]|not specified [RCV000611329] | ChrX:48904847 [GRCh38] ChrX:48762124 [GRCh37] ChrX:Xp11.23 |
benign|likely benign |
NM_005660.2(SLC35A2):c.-40dup | duplication | not specified [RCV000609085] | ChrX:48911671..48911672 [GRCh38] ChrX:48768948..48768949 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.348del (p.Val117fs) | deletion | SLC35A2-congenital disorder of glycosylation [RCV000651307] | ChrX:48906470 [GRCh38] ChrX:48763747 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.852G>T (p.Leu284=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000651309] | ChrX:48905057 [GRCh38] ChrX:48762334 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.750C>G (p.Leu250=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000651311] | ChrX:48905159 [GRCh38] ChrX:48762436 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.981C>T (p.Gly327=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001443972] | ChrX:48904928 [GRCh38] ChrX:48762205 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.639C>T (p.Ser213=) | single nucleotide variant | Inborn genetic diseases [RCV002315972]|SLC35A2-congenital disorder of glycosylation [RCV000651313] | ChrX:48905270 [GRCh38] ChrX:48762547 [GRCh37] ChrX:Xp11.23 |
benign|likely benign |
NC_000023.10:g.(?_48542223)_(48768933_?)dup | duplication | SLC35A2-congenital disorder of glycosylation [RCV000651314] | ChrX:48542223..48768933 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NC_000023.10:g.(?_48755773)_(48935774_?)dup | duplication | SLC35A2-congenital disorder of glycosylation [RCV000651315] | ChrX:48755773..48935774 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
GRCh37/hg19 Xp11.23-11.22(chrX:48224454-52813336)x3 | copy number gain | See cases [RCV000512224] | ChrX:48224454..52813336 [GRCh37] ChrX:Xp11.23-11.22 |
pathogenic |
GRCh37/hg19 Xp22.33-q13.3(chrX:168546-74549686) | copy number loss | See cases [RCV000512142] | ChrX:168546..74549686 [GRCh37] ChrX:Xp22.33-q13.3 |
pathogenic |
NM_005660.3(SLC35A2):c.1039G>A (p.Ala347Thr) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001511787]|not provided [RCV000513019] | ChrX:48904870 [GRCh38] ChrX:48762147 [GRCh37] ChrX:Xp11.23 |
benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_005660.3(SLC35A2):c.1078G>A (p.Val360Ile) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000651310]|not provided [RCV003437306]|not specified [RCV000606151] | ChrX:48904831 [GRCh38] ChrX:48762108 [GRCh37] ChrX:Xp11.23 |
benign|likely benign |
GRCh37/hg19 Xp11.23-11.22(chrX:48290189-52154997)x4 | copy number gain | See cases [RCV000512561] | ChrX:48290189..52154997 [GRCh37] ChrX:Xp11.23-11.22 |
pathogenic |
GRCh37/hg19 Xp22.33-11.21(chrX:168564-57413442)x1 | copy number loss | See cases [RCV000512339] | ChrX:168564..57413442 [GRCh37] ChrX:Xp22.33-11.21 |
pathogenic |
NM_005660.3(SLC35A2):c.818G>A (p.Gly273Asp) | single nucleotide variant | Inborn genetic diseases [RCV000623631] | ChrX:48905091 [GRCh38] ChrX:48762368 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
GRCh37/hg19 Xp22.31-q21.31(chrX:7841947-90815333)x1,2 | copy number gain | not provided [RCV000684261] | ChrX:7841947..90815333 [GRCh37] ChrX:Xp22.31-q21.31 |
pathogenic |
GRCh37/hg19 Xp11.23-11.22(chrX:48156672-52672728)x1 | copy number loss | not provided [RCV000684331] | ChrX:48156672..52672728 [GRCh37] ChrX:Xp11.23-11.22 |
pathogenic |
NM_005660.3(SLC35A2):c.619G>A (p.Val207Met) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000685207] | ChrX:48905290 [GRCh38] ChrX:48762567 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.523C>T (p.Leu175Phe) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000691195] | ChrX:48905386 [GRCh38] ChrX:48762663 [GRCh37] ChrX:Xp11.23 |
conflicting interpretations of pathogenicity|uncertain significance |
GRCh37/hg19 Xp22.33-11.22(chrX:60814-51821765)x1 | copy number loss | not provided [RCV000753274] | ChrX:60814..51821765 [GRCh37] ChrX:Xp22.33-11.22 |
pathogenic |
GRCh37/hg19 Xp22.33-11.21(chrX:60814-55476165)x1 | copy number loss | not provided [RCV000753275] | ChrX:60814..55476165 [GRCh37] ChrX:Xp22.33-11.21 |
pathogenic |
NM_005660.3(SLC35A2):c.169G>A (p.Ala57Thr) | single nucleotide variant | Inborn genetic diseases [RCV002318060]|SLC35A2-congenital disorder of glycosylation [RCV001056605] | ChrX:48909919 [GRCh38] ChrX:48767196 [GRCh37] ChrX:Xp11.23 |
benign|uncertain significance |
NM_005660.3(SLC35A2):c.1056T>C (p.Ser352=) | single nucleotide variant | Inborn genetic diseases [RCV002318788]|SLC35A2-congenital disorder of glycosylation [RCV000862426] | ChrX:48904853 [GRCh38] ChrX:48762130 [GRCh37] ChrX:Xp11.23 |
benign|likely benign |
NM_005660.3(SLC35A2):c.515T>C (p.Leu172Pro) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001004665] | ChrX:48905394 [GRCh38] ChrX:48762671 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
NC_000023.10:g.36649710_136649711del100000002insG | indel | Heterotaxy, visceral, 1, X-linked [RCV000754886] | ChrX:36649710..136649711 [GRCh37] ChrX:Xp21.1-q26.3 |
pathogenic |
GRCh37/hg19 Xp11.23-q13.2(chrX:48115450-73424191)x1 | copy number loss | not provided [RCV000753535] | ChrX:48115450..73424191 [GRCh37] ChrX:Xp11.23-q13.2 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:60814-155254881)x2 | copy number gain | not provided [RCV000753277] | ChrX:60814..155254881 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:60262-155245765)x1 | copy number loss | not provided [RCV000753271] | ChrX:60262..155245765 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:60262-155245765)x3 | copy number gain | not provided [RCV000753272] | ChrX:60262..155245765 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:181779-155171702)x1 | copy number loss | not provided [RCV000753278] | ChrX:181779..155171702 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:60814-155236712)x2 | copy number gain | not provided [RCV000753276] | ChrX:60814..155236712 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
Single allele | duplication | Autism [RCV000754365] | ChrX:1..156040895 [GRCh38] ChrX:Xp22.33-q28 |
pathogenic |
NM_005660.3(SLC35A2):c.579G>A (p.Arg193=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001471098] | ChrX:48905330 [GRCh38] ChrX:48762607 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.72G>T (p.Glu24Asp) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000861439]|SLC35A2-related condition [RCV003948055]|not provided [RCV001813805] | ChrX:48911565 [GRCh38] ChrX:48768842 [GRCh37] ChrX:Xp11.23 |
benign|likely benign |
NM_005660.3(SLC35A2):c.584T>G (p.Leu195Arg) | single nucleotide variant | Inborn genetic diseases [RCV002536590]|not provided [RCV000762634] | ChrX:48905325 [GRCh38] ChrX:48762602 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.520CTC[1] (p.Leu175del) | microsatellite | SLC35A2-congenital disorder of glycosylation [RCV000990814] | ChrX:48905384..48905386 [GRCh38] ChrX:48762661..48762663 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
NM_005660.3(SLC35A2):c.74C>T (p.Pro25Leu) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001066955] | ChrX:48911563 [GRCh38] ChrX:48768840 [GRCh37] ChrX:Xp11.23 |
benign|uncertain significance |
GRCh37/hg19 Xp22.33-11.21(chrX:539722-55509385)x1 | copy number loss | not provided [RCV001007224] | ChrX:539722..55509385 [GRCh37] ChrX:Xp22.33-11.21 |
pathogenic |
NM_005660.3(SLC35A2):c.578G>A (p.Arg193Gln) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001037501]|not provided [RCV000999416] | ChrX:48905331 [GRCh38] ChrX:48762608 [GRCh37] ChrX:Xp11.23 |
benign|uncertain significance |
NM_005660.3(SLC35A2):c.8C>T (p.Ala3Val) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001046470] | ChrX:48911629 [GRCh38] ChrX:48768906 [GRCh37] ChrX:Xp11.23 |
benign|uncertain significance |
NM_005660.3(SLC35A2):c.222G>C (p.Ala74=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001478193] | ChrX:48909866 [GRCh38] ChrX:48767143 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1146G>A (p.Thr382=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001485543] | ChrX:48904763 [GRCh38] ChrX:48762040 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.963C>T (p.Asp321=) | single nucleotide variant | not provided [RCV000926487] | ChrX:48904946 [GRCh38] ChrX:48762223 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.336G>T (p.Thr112=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001483425] | ChrX:48906482 [GRCh38] ChrX:48763759 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.837_843del (p.Phe280fs) | deletion | SLC35A2-congenital disorder of glycosylation [RCV001050910] | ChrX:48905066..48905072 [GRCh38] ChrX:48762343..48762349 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.35C>G (p.Ala12Gly) | single nucleotide variant | Inborn genetic diseases [RCV002551417]|SLC35A2-congenital disorder of glycosylation [RCV001038379] | ChrX:48911602 [GRCh38] ChrX:48768879 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
GRCh37/hg19 Xp11.23-11.22(chrX:48224266-52744574)x2 | copy number gain | not provided [RCV000847795] | ChrX:48224266..52744574 [GRCh37] ChrX:Xp11.23-11.22 |
pathogenic |
46,Y,inv(X)(p21.1q13.3) | inversion | Elevated circulating creatine kinase concentration [RCV000856573] | ChrX:32196272..75245806 [GRCh37] ChrX:Xp21.1-q13.3 |
likely pathogenic |
NM_005660.3(SLC35A2):c.771C>T (p.Ala257=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001520046] | ChrX:48905138 [GRCh38] ChrX:48762415 [GRCh37] ChrX:Xp11.23 |
benign |
GRCh37/hg19 Xp11.3-11.23(chrX:43507300-48929622) | copy number gain | not provided [RCV000767648] | ChrX:43507300..48929622 [GRCh37] ChrX:Xp11.3-11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.497G>A (p.Arg166Gln) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000802532]|not provided [RCV001585728] | ChrX:48905412 [GRCh38] ChrX:48762689 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.580C>A (p.Pro194Thr) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000796274] | ChrX:48905329 [GRCh38] ChrX:48762606 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.2T>A (p.Met1Lys) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000823050] | ChrX:48911635 [GRCh38] ChrX:48768912 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
NM_005660.3(SLC35A2):c.881A>G (p.Asn294Ser) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000800725]|not provided [RCV001509119] | ChrX:48905028 [GRCh38] ChrX:48762305 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
GRCh37/hg19 Xp11.4-q21.32(chrX:40572613-92796528)x1 | copy number loss | not provided [RCV000845670] | ChrX:40572613..92796528 [GRCh37] ChrX:Xp11.4-q21.32 |
pathogenic |
GRCh37/hg19 Xp11.23(chrX:48491182-48772769)x3 | copy number gain | not provided [RCV000845674] | ChrX:48491182..48772769 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.485G>A (p.Arg162His) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000791153] | ChrX:48905424 [GRCh38] ChrX:48762701 [GRCh37] ChrX:Xp11.23 |
conflicting interpretations of pathogenicity|uncertain significance |
NM_005660.3(SLC35A2):c.634_635del (p.Ser212fs) | microsatellite | SLC35A2-congenital disorder of glycosylation [RCV000785980]|non-lesional focal epilepsy [RCV001849444] | ChrX:48905274..48905275 [GRCh38] ChrX:48762551..48762552 [GRCh37] ChrX:Xp11.23 |
pathogenic|likely pathogenic |
NM_005660.3(SLC35A2):c.1096G>A (p.Gly366Arg) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000792956] | ChrX:48904813 [GRCh38] ChrX:48762090 [GRCh37] ChrX:Xp11.23 |
likely benign|uncertain significance |
GRCh37/hg19 Xp22.33-11.22(chrX:60814-50519984)x1 | copy number loss | See cases [RCV000790583] | ChrX:60814..50519984 [GRCh37] ChrX:Xp22.33-11.22 |
pathogenic |
NM_005660.3(SLC35A2):c.1130G>A (p.Arg377His) | single nucleotide variant | Inborn genetic diseases [RCV002539056]|SLC35A2-congenital disorder of glycosylation [RCV000869868] | ChrX:48904779 [GRCh38] ChrX:48762056 [GRCh37] ChrX:Xp11.23 |
benign|likely benign |
NM_005660.3(SLC35A2):c.828C>T (p.Leu276=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001079103]|not provided [RCV000861614] | ChrX:48905081 [GRCh38] ChrX:48762358 [GRCh37] ChrX:Xp11.23 |
benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_005660.3(SLC35A2):c.691G>A (p.Val231Met) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001858432]|not provided [RCV000838714] | ChrX:48905218 [GRCh38] ChrX:48762495 [GRCh37] ChrX:Xp11.23 |
likely benign|uncertain significance |
NM_005660.3(SLC35A2):c.324G>A (p.Gln108=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000979716] | ChrX:48906494 [GRCh38] ChrX:48763771 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1050TGCCTC[1] (p.349AS[3]) | microsatellite | SLC35A2-congenital disorder of glycosylation [RCV001065734] | ChrX:48904848..48904853 [GRCh38] ChrX:48762125..48762130 [GRCh37] ChrX:Xp11.23 |
benign|uncertain significance |
NM_005660.3(SLC35A2):c.818G>C (p.Gly273Ala) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001049784]|not provided [RCV000999415] | ChrX:48905091 [GRCh38] ChrX:48762368 [GRCh37] ChrX:Xp11.23 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_005660.3(SLC35A2):c.7del (p.Ala3fs) | deletion | not provided [RCV001009055] | ChrX:48911630 [GRCh38] ChrX:48768907 [GRCh37] ChrX:Xp11.23 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:168546-155233731)x1 | copy number loss | not provided [RCV000848828] | ChrX:168546..155233731 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
NM_005660.3(SLC35A2):c.427-4G>A | single nucleotide variant | not provided [RCV000999417] | ChrX:48905486 [GRCh38] ChrX:48762763 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.263C>T (p.Ala88Val) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001205372] | ChrX:48909825 [GRCh38] ChrX:48767102 [GRCh37] ChrX:Xp11.23 |
benign|uncertain significance |
NM_005660.3(SLC35A2):c.819C>T (p.Gly273=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001206300] | ChrX:48905090 [GRCh38] ChrX:48762367 [GRCh37] ChrX:Xp11.23 |
benign|uncertain significance |
GRCh37/hg19 Xp22.33-q28(chrX:168546-155233731)x4 | copy number gain | not provided [RCV000846039] | ChrX:168546..155233731 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
NM_005660.3(SLC35A2):c.966A>G (p.Pro322=) | single nucleotide variant | Inborn genetic diseases [RCV002372724]|SLC35A2-congenital disorder of glycosylation [RCV002068744]|not provided [RCV000999414] | ChrX:48904943 [GRCh38] ChrX:48762220 [GRCh37] ChrX:Xp11.23 |
likely benign|uncertain significance |
NM_005660.3(SLC35A2):c.92-7C>G | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001450426]|not provided [RCV000999419] | ChrX:48910003 [GRCh38] ChrX:48767280 [GRCh37] ChrX:Xp11.23 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_005660.3(SLC35A2):c.389_391del (p.Tyr130_Val131delinsPhe) | deletion | SLC35A2-congenital disorder of glycosylation [RCV000990815] | ChrX:48906427..48906429 [GRCh38] ChrX:48763704..48763706 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
NM_005660.3(SLC35A2):c.128T>C (p.Leu43Pro) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000990816] | ChrX:48909960 [GRCh38] ChrX:48767237 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
NM_005660.3(SLC35A2):c.844G>A (p.Gly282Arg) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002557952]|not provided [RCV001091019] | ChrX:48905065 [GRCh38] ChrX:48762342 [GRCh37] ChrX:Xp11.23 |
pathogenic|likely pathogenic |
GRCh37/hg19 Xp22.33-q11.1(chrX:168546-61877279)x1 | copy number loss | not provided [RCV000846273] | ChrX:168546..61877279 [GRCh37] ChrX:Xp22.33-q11.1 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:200855-155240074) | copy number gain | Klinefelter syndrome [RCV003236730] | ChrX:200855..155240074 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
NC_000023.10:g.(?_47001716)_(50659607_?)dup | duplication | Epilepsy, X-linked 1, with variable learning disabilities and behavior disorders [RCV003122411]|Neurodegeneration with brain iron accumulation 5 [RCV003105408]|SLC35A2-congenital disorder of glycosylation [RCV003122412] | ChrX:47001716..50659607 [GRCh37] ChrX:Xp11.23-11.22 |
uncertain significance |
NM_005660.3(SLC35A2):c.1147G>A (p.Glu383Lys) | single nucleotide variant | not provided [RCV003318123] | ChrX:48904762 [GRCh38] ChrX:48762039 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.1099C>A (p.Gln367Lys) | single nucleotide variant | Inborn genetic diseases [RCV002568362]|SLC35A2-congenital disorder of glycosylation [RCV003741265]|SLC35A2-related condition [RCV003921213]|not provided [RCV001556659] | ChrX:48904810 [GRCh38] ChrX:48762087 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.31G>T (p.Ala11Ser) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001907707] | ChrX:48911606 [GRCh38] ChrX:48768883 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.59C>T (p.Ala20Val) | single nucleotide variant | not provided [RCV001568089] | ChrX:48911578 [GRCh38] ChrX:48768855 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.426+188= | single nucleotide variant | not provided [RCV001652449] | ChrX:48906204 [GRCh38] ChrX:48763481 [GRCh37] ChrX:Xp11.23 |
benign |
NM_005660.3(SLC35A2):c.646G>A (p.Ala216Thr) | single nucleotide variant | not provided [RCV000971986] | ChrX:48905263 [GRCh38] ChrX:48762540 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.690C>T (p.Ser230=) | single nucleotide variant | not provided [RCV000862855] | ChrX:48905219 [GRCh38] ChrX:48762496 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.534C>T (p.Gly178=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002536785] | ChrX:48905375 [GRCh38] ChrX:48762652 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1063G>A (p.Ala355Thr) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001523443] | ChrX:48904846 [GRCh38] ChrX:48762123 [GRCh37] ChrX:Xp11.23 |
benign |
NM_005660.3(SLC35A2):c.275-9C>A | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001070781] | ChrX:48906552 [GRCh38] ChrX:48763829 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.841G>A (p.Gly281Ser) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001219843] | ChrX:48905068 [GRCh38] ChrX:48762345 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.831C>T (p.Asn277=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001409121] | ChrX:48905078 [GRCh38] ChrX:48762355 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.577C>A (p.Arg193=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001432806] | ChrX:48905332 [GRCh38] ChrX:48762609 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.253C>T (p.Leu85=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV000935574] | ChrX:48909835 [GRCh38] ChrX:48767112 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.252G>A (p.Leu84=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001488643]|not provided [RCV000999418] | ChrX:48909836 [GRCh38] ChrX:48767113 [GRCh37] ChrX:Xp11.23 |
likely benign|uncertain significance |
NM_005660.3(SLC35A2):c.426+65A>G | single nucleotide variant | not provided [RCV001581042] | ChrX:48906327 [GRCh38] ChrX:48763604 [GRCh37] ChrX:Xp11.23 |
likely benign |
GRCh37/hg19 Xp11.23-11.22(chrX:47179068-54424785)x2 | copy number gain | not provided [RCV001537899] | ChrX:47179068..54424785 [GRCh37] ChrX:Xp11.23-11.22 |
pathogenic |
NC_000023.11:g.48912103= | single nucleotide variant | not provided [RCV001659194] | ChrX:48912103 [GRCh38] ChrX:48769380 [GRCh37] ChrX:Xp11.23 |
benign |
NM_005660.3(SLC35A2):c.941G>A (p.Arg314His) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001229116] | ChrX:48904968 [GRCh38] ChrX:48762245 [GRCh37] ChrX:Xp11.23 |
benign|uncertain significance |
NM_005660.3(SLC35A2):c.1096G>T (p.Gly366Trp) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001071636] | ChrX:48904813 [GRCh38] ChrX:48762090 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
GRCh37/hg19 Xp11.23-11.22(chrX:48307437-50657313)x3 | copy number gain | not provided [RCV001007303] | ChrX:48307437..50657313 [GRCh37] ChrX:Xp11.23-11.22 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:60000-155234966)x1 | copy number loss | not provided [RCV001537933] | ChrX:60000..155234966 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
NM_005660.2(SLC35A2):c.-190T>G | single nucleotide variant | not provided [RCV001725292] | ChrX:48911826 [GRCh38] ChrX:48769103 [GRCh37] ChrX:Xp11.23 |
benign |
NM_005660.3(SLC35A2):c.1164-51G>A | single nucleotide variant | not provided [RCV001651590] | ChrX:48903516 [GRCh38] ChrX:48760793 [GRCh37] ChrX:Xp11.23 |
benign |
NM_005660.3(SLC35A2):c.615C>T (p.Ala205=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001470052]|not provided [RCV001200323] | ChrX:48905294 [GRCh38] ChrX:48762571 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.982G>A (p.Ala328Thr) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003741248]|not provided [RCV001200322] | ChrX:48904927 [GRCh38] ChrX:48762204 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.465C>G (p.Phe155Leu) | single nucleotide variant | not provided [RCV001091498] | ChrX:48905444 [GRCh38] ChrX:48762721 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.1112C>T (p.Pro371Leu) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001204715] | ChrX:48904797 [GRCh38] ChrX:48762074 [GRCh37] ChrX:Xp11.23 |
benign|uncertain significance |
NM_005660.3(SLC35A2):c.562G>A (p.Gly188Ser) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001211097]|not provided [RCV002255177] | ChrX:48905347 [GRCh38] ChrX:48762624 [GRCh37] ChrX:Xp11.23 |
likely pathogenic|benign|uncertain significance |
NM_005660.3(SLC35A2):c.947_948del (p.Phe316fs) | deletion | SLC35A2-congenital disorder of glycosylation [RCV001063440] | ChrX:48904961..48904962 [GRCh38] ChrX:48762238..48762239 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.700C>T (p.Arg234Cys) | single nucleotide variant | Inborn genetic diseases [RCV002365781]|SLC35A2-congenital disorder of glycosylation [RCV001070846] | ChrX:48905209 [GRCh38] ChrX:48762486 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
GRCh37/hg19 Xp11.23-11.22(chrX:48102202-52685635)x2 | copy number gain | not provided [RCV001258953] | ChrX:48102202..52685635 [GRCh37] ChrX:Xp11.23-11.22 |
pathogenic |
GRCh37/hg19 Xp11.23-11.22(chrX:48178413-52686510)x2 | copy number gain | not provided [RCV001258954] | ChrX:48178413..52686510 [GRCh37] ChrX:Xp11.23-11.22 |
pathogenic |
NM_005660.3(SLC35A2):c.335C>G (p.Thr112Arg) | single nucleotide variant | Inborn genetic diseases [RCV001267207] | ChrX:48906483 [GRCh38] ChrX:48763760 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
GRCh37/hg19 Xp22.33-q28(chrX:1-155270560) | copy number gain | 46,XX sex reversal 1 [RCV002280665]|Hypotonia [RCV002280667]|Trisomy X syndrome [RCV002280666] | ChrX:1..155270560 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-11.22(chrX:168546-52573789) | copy number loss | Turner syndrome [RCV002280669] | ChrX:168546..52573789 [GRCh37] ChrX:Xp22.33-11.22 |
pathogenic |
NM_005660.3(SLC35A2):c.696G>A (p.Trp232Ter) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001265566] | ChrX:48905213 [GRCh38] ChrX:48762490 [GRCh37] ChrX:Xp11.23 |
pathogenic |
GRCh37/hg19 Xp22.33-11.21(chrX:168546-57841304) | copy number loss | Turner syndrome [RCV002280671] | ChrX:168546..57841304 [GRCh37] ChrX:Xp22.33-11.21 |
pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:1-155270560) | copy number loss | Turner syndrome [RCV002280668] | ChrX:1..155270560 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.33-11.21(chrX:219609-55466476)x1 | copy number loss | See cases [RCV001263061] | ChrX:219609..55466476 [GRCh37] ChrX:Xp22.33-11.21 |
pathogenic |
NM_005660.3(SLC35A2):c.1025G>A (p.Arg342Gln) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001338780] | ChrX:48904884 [GRCh38] ChrX:48762161 [GRCh37] ChrX:Xp11.23 |
benign|uncertain significance |
NM_005660.3(SLC35A2):c.340A>T (p.Lys114Ter) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001331522] | ChrX:48906478 [GRCh38] ChrX:48763755 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.177G>C (p.Thr59=) | single nucleotide variant | not provided [RCV001311071] | ChrX:48909911 [GRCh38] ChrX:48767188 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.566G>A (p.Gly189Glu) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001359855]|not provided [RCV003222310] | ChrX:48905343 [GRCh38] ChrX:48762620 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.991_993del (p.Val331del) | deletion | SLC35A2-congenital disorder of glycosylation [RCV001346389] | ChrX:48904916..48904918 [GRCh38] ChrX:48762193..48762195 [GRCh37] ChrX:Xp11.23 |
pathogenic|uncertain significance |
NM_005660.3(SLC35A2):c.101G>A (p.Arg34His) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001364069] | ChrX:48909987 [GRCh38] ChrX:48767264 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.989T>C (p.Leu330Pro) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001289474] | ChrX:48904920 [GRCh38] ChrX:48762197 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
NM_005660.3(SLC35A2):c.1050TGCCTC[3] (p.349AS[5]) | microsatellite | SLC35A2-congenital disorder of glycosylation [RCV001306706] | ChrX:48904847..48904848 [GRCh38] ChrX:48762124..48762125 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
GRCh37/hg19 Xp22.33-11.21(chrX:168546-56457794)x1 | copy number loss | not provided [RCV001281358] | ChrX:168546..56457794 [GRCh37] ChrX:Xp22.33-11.21 |
pathogenic |
NM_005660.3(SLC35A2):c.426+1G>A | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001374455] | ChrX:48906391 [GRCh38] ChrX:48763668 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NC_000023.10:g.(?_48382160)_(49856876_?)dup | duplication | Neurodegeneration with brain iron accumulation 5 [RCV001305099]|SLC35A2-congenital disorder of glycosylation [RCV001308190] | ChrX:48382160..49856876 [GRCh37] ChrX:Xp11.23-11.22 |
uncertain significance |
NM_005660.3(SLC35A2):c.781del (p.Arg261fs) | deletion | SLC35A2-congenital disorder of glycosylation [RCV001374456] | ChrX:48905128 [GRCh38] ChrX:48762405 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.601del (p.Ala201fs) | deletion | SLC35A2-congenital disorder of glycosylation [RCV001374458] | ChrX:48905308 [GRCh38] ChrX:48762585 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.1077C>T (p.Cys359=) | single nucleotide variant | Inborn genetic diseases [RCV002420925]|SLC35A2-congenital disorder of glycosylation [RCV001412766] | ChrX:48904832 [GRCh38] ChrX:48762109 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1129C>T (p.Arg377Cys) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002070238]|not provided [RCV001358343] | ChrX:48904780 [GRCh38] ChrX:48762057 [GRCh37] ChrX:Xp11.23 |
benign|likely benign |
NM_005660.3(SLC35A2):c.801C>T (p.Tyr267=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001482257] | ChrX:48905108 [GRCh38] ChrX:48762385 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.339C>G (p.Leu113=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001504890] | ChrX:48906479 [GRCh38] ChrX:48763756 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.279C>T (p.Asn93=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001511087]|SLC35A2-related condition [RCV003940893] | ChrX:48906539 [GRCh38] ChrX:48763816 [GRCh37] ChrX:Xp11.23 |
benign|likely benign |
NM_005660.3(SLC35A2):c.216C>T (p.Val72=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001462879] | ChrX:48909872 [GRCh38] ChrX:48767149 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.327T>G (p.Tyr109Ter) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001385378] | ChrX:48906491 [GRCh38] ChrX:48763768 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.1015A>G (p.Ser339Gly) | single nucleotide variant | Inborn genetic diseases [RCV002568768]|SLC35A2-congenital disorder of glycosylation [RCV001523626] | ChrX:48904894 [GRCh38] ChrX:48762171 [GRCh37] ChrX:Xp11.23 |
benign|likely benign |
NM_005660.3(SLC35A2):c.1069G>A (p.Gly357Arg) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001517306] | ChrX:48904840 [GRCh38] ChrX:48762117 [GRCh37] ChrX:Xp11.23 |
benign |
NM_005660.3(SLC35A2):c.810T>C (p.Ala270=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001477053] | ChrX:48905099 [GRCh38] ChrX:48762376 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.201C>T (p.Ala67=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001415553] | ChrX:48909887 [GRCh38] ChrX:48767164 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1110A>G (p.Pro370=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001521518] | ChrX:48904799 [GRCh38] ChrX:48762076 [GRCh37] ChrX:Xp11.23 |
benign |
NM_005660.3(SLC35A2):c.747G>T (p.Gly249=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001393476] | ChrX:48905162 [GRCh38] ChrX:48762439 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.768C>T (p.Thr256=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001492034] | ChrX:48905141 [GRCh38] ChrX:48762418 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.369C>T (p.Thr123=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001445853] | ChrX:48906449 [GRCh38] ChrX:48763726 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.486C>T (p.Arg162=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001448563] | ChrX:48905423 [GRCh38] ChrX:48762700 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.429G>A (p.Val143=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001406949] | ChrX:48905480 [GRCh38] ChrX:48762757 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.656_660del (p.Val218_Tyr219insTer) | deletion | SLC35A2-congenital disorder of glycosylation [RCV001384855] | ChrX:48905249..48905253 [GRCh38] ChrX:48762526..48762530 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NC_000023.10:g.(?_48762413)_(48763384_?)del | deletion | SLC35A2-congenital disorder of glycosylation [RCV001384880] | ChrX:48762413..48763384 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.1058CCTCCG[3] (p.349AS[5]) | microsatellite | SLC35A2-congenital disorder of glycosylation [RCV001418201] | ChrX:48904839..48904840 [GRCh38] ChrX:48762116..48762117 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.345C>T (p.Leu115=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001518814] | ChrX:48906473 [GRCh38] ChrX:48763750 [GRCh37] ChrX:Xp11.23 |
benign |
NM_005660.3(SLC35A2):c.1145C>T (p.Thr382Met) | single nucleotide variant | Inborn genetic diseases [RCV003161047]|SLC35A2-congenital disorder of glycosylation [RCV001521064] | ChrX:48904764 [GRCh38] ChrX:48762041 [GRCh37] ChrX:Xp11.23 |
benign|likely benign |
NM_005660.3(SLC35A2):c.1050T>C (p.Ser350=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001487896] | ChrX:48904859 [GRCh38] ChrX:48762136 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1130G>C (p.Arg377Pro) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001516279] | ChrX:48904779 [GRCh38] ChrX:48762056 [GRCh37] ChrX:Xp11.23 |
benign |
NM_005660.3(SLC35A2):c.1113G>A (p.Pro371=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001455882] | ChrX:48904796 [GRCh38] ChrX:48762073 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.92-6C>T | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001434700] | ChrX:48910002 [GRCh38] ChrX:48767279 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.873C>T (p.Tyr291=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001489167] | ChrX:48905036 [GRCh38] ChrX:48762313 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.724G>A (p.Gly242Ser) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001416887] | ChrX:48905185 [GRCh38] ChrX:48762462 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1A>T (p.Met1Leu) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002246722] | ChrX:48911636 [GRCh38] ChrX:48768913 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.1163+70G>A | single nucleotide variant | See cases [RCV002252506] | ChrX:48904676 [GRCh38] ChrX:48761953 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_001032382.2(PQBP1):c.640C>T (p.Arg214Trp) | single nucleotide variant | Renpenning syndrome [RCV002477949]|not provided [RCV001763279] | ChrX:48902794 [GRCh38] ChrX:48760071 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_001032382.2(PQBP1):c.758G>A (p.Arg253Gln) | single nucleotide variant | not provided [RCV001751874] | ChrX:48903044 [GRCh38] ChrX:48760321 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.1096_1163+217delinsCGGGAGG | indel | not provided [RCV001757139] | ChrX:48904529..48904813 [GRCh38] ChrX:48761806..48762090 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.803C>T (p.Thr268Ile) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001814875] | ChrX:48905106 [GRCh38] ChrX:48762383 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
NM_001032382.2(PQBP1):c.649T>C (p.Trp217Arg) | single nucleotide variant | not provided [RCV001806476] | ChrX:48902935 [GRCh38] ChrX:48760212 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.747_757dup (p.Ala253fs) | duplication | non-lesional focal epilepsy [RCV001849583] | ChrX:48905151..48905152 [GRCh38] ChrX:48762428..48762429 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
NM_005660.3(SLC35A2):c.1073C>T (p.Pro358Leu) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001949720] | ChrX:48904836 [GRCh38] ChrX:48762113 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.685G>A (p.Gly229Ser) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002004717] | ChrX:48905224 [GRCh38] ChrX:48762501 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.164G>T (p.Arg55Leu) | single nucleotide variant | non-lesional focal epilepsy [RCV001849582] | ChrX:48909924 [GRCh38] ChrX:48767201 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
NM_005660.3(SLC35A2):c.769G>A (p.Ala257Thr) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001892937] | ChrX:48905140 [GRCh38] ChrX:48762417 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
GRCh37/hg19 Xp22.33-q28(chrX:168546-155233731)x1 | copy number loss | not provided [RCV001834509] | ChrX:168546..155233731 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
NM_005660.3(SLC35A2):c.337_339dup (p.Leu113dup) | duplication | non-lesional focal epilepsy [RCV001849887] | ChrX:48906478..48906479 [GRCh38] ChrX:48763755..48763756 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
NM_005660.3(SLC35A2):c.176C>T (p.Thr59Met) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001894161] | ChrX:48909912 [GRCh38] ChrX:48767189 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.820G>A (p.Val274Met) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001911559] | ChrX:48905089 [GRCh38] ChrX:48762366 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.910T>C (p.Ser304Pro) | single nucleotide variant | non-lesional focal epilepsy [RCV001849886] | ChrX:48904999 [GRCh38] ChrX:48762276 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
GRCh37/hg19 Xp22.33-q28(chrX:168546-155233731)x3 | copy number gain | not provided [RCV001829212] | ChrX:168546..155233731 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
NM_005660.3(SLC35A2):c.781C>T (p.Arg261Cys) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001924319] | ChrX:48905128 [GRCh38] ChrX:48762405 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.1100A>G (p.Gln367Arg) | single nucleotide variant | Inborn genetic diseases [RCV002563575]|SLC35A2-congenital disorder of glycosylation [RCV001989879] | ChrX:48904809 [GRCh38] ChrX:48762086 [GRCh37] ChrX:Xp11.23 |
likely benign|uncertain significance |
NM_005660.3(SLC35A2):c.616G>A (p.Val206Ile) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001931379] | ChrX:48905293 [GRCh38] ChrX:48762570 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.197T>C (p.Phe66Ser) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001975578] | ChrX:48909891 [GRCh38] ChrX:48767168 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.136C>T (p.Gln46Ter) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001956129] | ChrX:48909952 [GRCh38] ChrX:48767229 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.385C>T (p.Gln129Ter) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001997611] | ChrX:48906433 [GRCh38] ChrX:48763710 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.1030G>A (p.Ala344Thr) | single nucleotide variant | Inborn genetic diseases [RCV002642185]|SLC35A2-congenital disorder of glycosylation [RCV002026038] | ChrX:48904879 [GRCh38] ChrX:48762156 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.194T>C (p.Phe65Ser) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001998629] | ChrX:48909894 [GRCh38] ChrX:48767171 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.1105C>T (p.Pro369Ser) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001938547] | ChrX:48904804 [GRCh38] ChrX:48762081 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.955C>T (p.His319Tyr) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV001907356] | ChrX:48904954 [GRCh38] ChrX:48762231 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.92-11G>A | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002129681] | ChrX:48910007 [GRCh38] ChrX:48767284 [GRCh37] ChrX:Xp11.23 |
benign |
NM_005660.3(SLC35A2):c.958G>A (p.Val320Met) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002090552] | ChrX:48904951 [GRCh38] ChrX:48762228 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.187G>A (p.Asp63Asn) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002106204] | ChrX:48909901 [GRCh38] ChrX:48767178 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.840C>T (p.Phe280=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002208253] | ChrX:48905069 [GRCh38] ChrX:48762346 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.261C>T (p.Phe87=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002214773] | ChrX:48909827 [GRCh38] ChrX:48767104 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.496C>T (p.Arg166Trp) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002153043]|not provided [RCV002269391] | ChrX:48905413 [GRCh38] ChrX:48762690 [GRCh37] ChrX:Xp11.23 |
likely benign|uncertain significance |
NM_005660.3(SLC35A2):c.957C>T (p.His319=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002144924] | ChrX:48904952 [GRCh38] ChrX:48762229 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.112A>C (p.Ile38Leu) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002090265] | ChrX:48909976 [GRCh38] ChrX:48767253 [GRCh37] ChrX:Xp11.23 |
benign |
NM_005660.3(SLC35A2):c.1156C>T (p.Leu386=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002094587] | ChrX:48904753 [GRCh38] ChrX:48762030 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.468C>T (p.Ser156=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002173054] | ChrX:48905441 [GRCh38] ChrX:48762718 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1014C>T (p.Tyr338=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002094405] | ChrX:48904895 [GRCh38] ChrX:48762172 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.426+17G>A | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002112357] | ChrX:48906375 [GRCh38] ChrX:48763652 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.112A>T (p.Ile38Leu) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002244152] | ChrX:48909976 [GRCh38] ChrX:48767253 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.275-17C>T | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002184607] | ChrX:48906560 [GRCh38] ChrX:48763837 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.280G>A (p.Val94Met) | single nucleotide variant | SLC35A2-related condition [RCV003933711]|See cases [RCV002253176] | ChrX:48906538 [GRCh38] ChrX:48763815 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.723C>T (p.Phe241=) | single nucleotide variant | Inborn genetic diseases [RCV002372924]|SLC35A2-congenital disorder of glycosylation [RCV002119728] | ChrX:48905186 [GRCh38] ChrX:48762463 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.610G>A (p.Ala204Thr) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002099643]|SLC35A2-related condition [RCV003403670] | ChrX:48905299 [GRCh38] ChrX:48762576 [GRCh37] ChrX:Xp11.23 |
benign|uncertain significance |
NM_005660.3(SLC35A2):c.343C>T (p.Leu115Phe) | single nucleotide variant | not provided [RCV003109882] | ChrX:48906475 [GRCh38] ChrX:48763752 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NC_000023.10:g.(?_48368209)_(51241672_?)dup | duplication | X-linked severe congenital neutropenia [RCV003111119] | ChrX:48368209..51241672 [GRCh37] ChrX:Xp11.23-11.22 |
uncertain significance |
NC_000023.10:g.(?_46466387)_(50659607_?)del | deletion | Insulin-dependent diabetes mellitus secretory diarrhea syndrome [RCV003116676] | ChrX:46466387..50659607 [GRCh37] ChrX:Xp11.23-11.22 |
pathogenic |
NC_000023.10:g.(?_48368209)_(51241672_?)del | deletion | not provided [RCV003116321] | ChrX:48368209..51241672 [GRCh37] ChrX:Xp11.23-11.22 |
pathogenic |
NM_005660.3(SLC35A2):c.1163+54del | deletion | not specified [RCV003123452] | ChrX:48904692 [GRCh38] ChrX:48761969 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.1128C>T (p.His376=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003121040] | ChrX:48904781 [GRCh38] ChrX:48762058 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.795dup (p.Gly266fs) | duplication | SLC35A2-congenital disorder of glycosylation [RCV003148558] | ChrX:48905113..48905114 [GRCh38] ChrX:48762390..48762391 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
NM_005660.2(SLC35A2):c.-222G>C | single nucleotide variant | not provided [RCV002276223] | ChrX:48911858 [GRCh38] ChrX:48769135 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
GRCh37/hg19 Xp22.33-q28(chrX:61545-155226048)x2 | copy number gain | Klinefelter syndrome [RCV002282732] | ChrX:61545..155226048 [GRCh37] ChrX:Xp22.33-q28 |
pathogenic |
GRCh37/hg19 Xp22.2-q28(chrX:11522765-155233731)x1 | copy number loss | See cases [RCV002286357] | ChrX:11522765..155233731 [GRCh37] ChrX:Xp22.2-q28 |
pathogenic |
NM_005660.3(SLC35A2):c.484C>A (p.Arg162Ser) | single nucleotide variant | not provided [RCV002265261] | ChrX:48905425 [GRCh38] ChrX:48762702 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.56C>T (p.Ser19Phe) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003095988]|not provided [RCV002265270] | ChrX:48911581 [GRCh38] ChrX:48768858 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
Single allele | complex | Turner syndrome [RCV002280670] | ChrX:590376..56315041 [GRCh37] ChrX:Xp22.33-11.21 |
pathogenic |
NM_005660.3(SLC35A2):c.26C>T (p.Ser9Phe) | single nucleotide variant | Inborn genetic diseases [RCV002437386] | ChrX:48911611 [GRCh38] ChrX:48768888 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.308A>T (p.Glu103Val) | single nucleotide variant | Congenital disorder of glycosylation [RCV003152647] | ChrX:48906510 [GRCh38] ChrX:48763787 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
GRCh37/hg19 Xp11.4-11.22(chrX:39525562-52832596)x3 | copy number gain | not provided [RCV002474503] | ChrX:39525562..52832596 [GRCh37] ChrX:Xp11.4-11.22 |
pathogenic |
NM_005660.3(SLC35A2):c.940C>T (p.Arg314Cys) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002685996] | ChrX:48904969 [GRCh38] ChrX:48762246 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.274+8C>T | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003017062] | ChrX:48909806 [GRCh38] ChrX:48767083 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.595C>G (p.Pro199Ala) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003074458] | ChrX:48905314 [GRCh38] ChrX:48762591 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.91+9G>C | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003075683] | ChrX:48911537 [GRCh38] ChrX:48768814 [GRCh37] ChrX:Xp11.23 |
benign |
NM_005660.3(SLC35A2):c.520C>T (p.Leu174Phe) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003033883] | ChrX:48905389 [GRCh38] ChrX:48762666 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.1118T>C (p.Leu373Pro) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003021429] | ChrX:48904791 [GRCh38] ChrX:48762068 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.91+16C>G | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002871223] | ChrX:48911530 [GRCh38] ChrX:48768807 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.66A>C (p.Ala22=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002593439] | ChrX:48911571 [GRCh38] ChrX:48768848 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.427-14C>T | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002846784] | ChrX:48905496 [GRCh38] ChrX:48762773 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.842G>T (p.Gly281Val) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002909308] | ChrX:48905067 [GRCh38] ChrX:48762344 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.645C>T (p.Phe215=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002923662] | ChrX:48905264 [GRCh38] ChrX:48762541 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.66A>G (p.Ala22=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002886359] | ChrX:48911571 [GRCh38] ChrX:48768848 [GRCh37] ChrX:Xp11.23 |
benign |
NM_005660.3(SLC35A2):c.616G>T (p.Val206Phe) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002866926] | ChrX:48905293 [GRCh38] ChrX:48762570 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.938T>C (p.Ile313Thr) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003008363] | ChrX:48904971 [GRCh38] ChrX:48762248 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.1068C>T (p.Ser356=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002890657] | ChrX:48904841 [GRCh38] ChrX:48762118 [GRCh37] ChrX:Xp11.23 |
benign |
NM_005660.3(SLC35A2):c.962A>G (p.Asp321Gly) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002594837] | ChrX:48904947 [GRCh38] ChrX:48762224 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.288C>G (p.His96Gln) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002928788] | ChrX:48906530 [GRCh38] ChrX:48763807 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.168C>T (p.Tyr56=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002985546] | ChrX:48909920 [GRCh38] ChrX:48767197 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.38C>T (p.Pro13Leu) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003031295] | ChrX:48911599 [GRCh38] ChrX:48768876 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.439C>T (p.Leu147=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002922107]|not provided [RCV003435836] | ChrX:48905470 [GRCh38] ChrX:48762747 [GRCh37] ChrX:Xp11.23 |
benign|likely benign |
NM_005660.3(SLC35A2):c.757G>A (p.Ala253Thr) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002833534] | ChrX:48905152 [GRCh38] ChrX:48762429 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.426+16A>G | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002833557] | ChrX:48906376 [GRCh38] ChrX:48763653 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.274+17G>C | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002629194] | ChrX:48909797 [GRCh38] ChrX:48767074 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1042A>G (p.Ile348Val) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002597414]|not provided [RCV003439028] | ChrX:48904867 [GRCh38] ChrX:48762144 [GRCh37] ChrX:Xp11.23 |
benign|likely benign |
NM_005660.3(SLC35A2):c.327T>C (p.Tyr109=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002938091] | ChrX:48906491 [GRCh38] ChrX:48763768 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.571G>A (p.Gly191Ser) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003046068] | ChrX:48905338 [GRCh38] ChrX:48762615 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.538G>A (p.Ala180Thr) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002579144] | ChrX:48905371 [GRCh38] ChrX:48762648 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.775G>A (p.Ala259Thr) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003060167] | ChrX:48905134 [GRCh38] ChrX:48762411 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.669C>T (p.Ile223=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002937977] | ChrX:48905240 [GRCh38] ChrX:48762517 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.30C>T (p.Thr10=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003091477] | ChrX:48911607 [GRCh38] ChrX:48768884 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1021C>T (p.Pro341Ser) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003031041] | ChrX:48904888 [GRCh38] ChrX:48762165 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.1030G>T (p.Ala344Ser) | single nucleotide variant | Inborn genetic diseases [RCV002962982]|SLC35A2-congenital disorder of glycosylation [RCV002962983] | ChrX:48904879 [GRCh38] ChrX:48762156 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.91+14C>A | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003071721] | ChrX:48911532 [GRCh38] ChrX:48768809 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.782G>A (p.Arg261His) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV002611180] | ChrX:48905127 [GRCh38] ChrX:48762404 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.367A>G (p.Thr123Ala) | single nucleotide variant | not provided [RCV003149528] | ChrX:48906451 [GRCh38] ChrX:48763728 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NC_000023.10:g.(?_46466387)_(51241672_?)del | deletion | not provided [RCV003154905] | ChrX:46466387..51241672 [GRCh37] ChrX:Xp11.23-11.22 |
pathogenic |
NM_001032382.2(PQBP1):c.731C>G (p.Pro244Arg) | single nucleotide variant | not provided [RCV003149483] | ChrX:48903017 [GRCh38] ChrX:48760294 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.832C>T (p.Gln278Ter) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003321453] | ChrX:48905077 [GRCh38] ChrX:48762354 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_001032382.2(PQBP1):c.642-5G>A | single nucleotide variant | not provided [RCV001091018] | ChrX:48902923 [GRCh38] ChrX:48760200 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.1112C>A (p.Pro371Gln) | single nucleotide variant | not provided [RCV003319125] | ChrX:48904797 [GRCh38] ChrX:48762074 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.1069G>C (p.Gly357Arg) | single nucleotide variant | Autism [RCV003328510]|SLC35A2-congenital disorder of glycosylation [RCV003741345] | ChrX:48904840 [GRCh38] ChrX:48762117 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_001282648.2(SLC35A2):c.19+5G>T | single nucleotide variant | SLC35A2-related condition [RCV003397349] | ChrX:48911854 [GRCh38] ChrX:48769131 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.1163+142C>A | single nucleotide variant | not provided [RCV003332903] | ChrX:48904604 [GRCh38] ChrX:48761881 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.2(SLC35A2):c.-15C>A | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003741147] | ChrX:48911651 [GRCh38] ChrX:48768928 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
GRCh37/hg19 Xp21.1-11.22(chrX:36355238-54106257)x1 | copy number loss | not provided [RCV003483920] | ChrX:36355238..54106257 [GRCh37] ChrX:Xp21.1-11.22 |
pathogenic |
GRCh37/hg19 Xp22.33-11.22(chrX:2696762-53113314)x1 | copy number loss | not provided [RCV003483407] | ChrX:2696762..53113314 [GRCh37] ChrX:Xp22.33-11.22 |
pathogenic |
GRCh37/hg19 Xp11.23-11.22(chrX:48224455-52832596)x3 | copy number gain | not provided [RCV003485288] | ChrX:48224455..52832596 [GRCh37] ChrX:Xp11.23-11.22 |
pathogenic |
NM_005660.3(SLC35A2):c.1163+105G>A | single nucleotide variant | not provided [RCV003438259] | ChrX:48904641 [GRCh38] ChrX:48761918 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_001032382.2(PQBP1):c.668A>G (p.Lys223Arg) | single nucleotide variant | not provided [RCV003442588] | ChrX:48902954 [GRCh38] ChrX:48760231 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.652G>A (p.Val218Ile) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003581938]|not provided [RCV003438260] | ChrX:48905257 [GRCh38] ChrX:48762534 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.755G>A (p.Trp252Ter) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003389937] | ChrX:48905154 [GRCh38] ChrX:48762431 [GRCh37] ChrX:Xp11.23 |
not provided |
NM_005660.3(SLC35A2):c.*32G>A | single nucleotide variant | not provided [RCV003438258] | ChrX:48903406 [GRCh38] ChrX:48760683 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.288C>T (p.His96=) | single nucleotide variant | not provided [RCV003438261] | ChrX:48906530 [GRCh38] ChrX:48763807 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.843C>T (p.Gly281=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003848888] | ChrX:48905066 [GRCh38] ChrX:48762343 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.541A>G (p.Ile181Val) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003882756] | ChrX:48905368 [GRCh38] ChrX:48762645 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.200C>T (p.Ala67Val) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003878510] | ChrX:48909888 [GRCh38] ChrX:48767165 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_001042498.3:c.923C>T | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003882755] | pathogenic | |
NM_005660.3(SLC35A2):c.484C>T (p.Arg162Cys) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003742567] | ChrX:48905425 [GRCh38] ChrX:48762702 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.8C>A (p.Ala3Glu) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003582890] | ChrX:48911629 [GRCh38] ChrX:48768906 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.458C>T (p.Ala153Val) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003741964] | ChrX:48905451 [GRCh38] ChrX:48762728 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.68dup (p.Leu23fs) | duplication | SLC35A2-congenital disorder of glycosylation [RCV003582065] | ChrX:48911568..48911569 [GRCh38] ChrX:48768845..48768846 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.11_16del (p.Val4_Gly5del) | deletion | SLC35A2-congenital disorder of glycosylation [RCV003740807] | ChrX:48911621..48911626 [GRCh38] ChrX:48768898..48768903 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.92-12C>A | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003742164] | ChrX:48910008 [GRCh38] ChrX:48767285 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.275-19C>G | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003740899] | ChrX:48906562 [GRCh38] ChrX:48763839 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.660T>C (p.Phe220=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003582280] | ChrX:48905249 [GRCh38] ChrX:48762526 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.73C>A (p.Pro25Thr) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003740897] | ChrX:48911564 [GRCh38] ChrX:48768841 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.150C>A (p.Leu50=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003741093] | ChrX:48909938 [GRCh38] ChrX:48767215 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.92-20G>A | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003742367] | ChrX:48910016 [GRCh38] ChrX:48767293 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.321G>A (p.Val107=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003742390] | ChrX:48906497 [GRCh38] ChrX:48763774 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.179T>C (p.Leu60Ser) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003582685] | ChrX:48909909 [GRCh38] ChrX:48767186 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.111C>T (p.Tyr37=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003742505] | ChrX:48909977 [GRCh38] ChrX:48767254 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.21T>G (p.Gly7=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003582325] | ChrX:48911616 [GRCh38] ChrX:48768893 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.568G>A (p.Gly190Arg) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003742460] | ChrX:48905341 [GRCh38] ChrX:48762618 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.825G>C (p.Val275=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003582547] | ChrX:48905084 [GRCh38] ChrX:48762361 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1078G>C (p.Val360Leu) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003581983] | ChrX:48904831 [GRCh38] ChrX:48762108 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.78G>T (p.Gly26=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003582015] | ChrX:48911559 [GRCh38] ChrX:48768836 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1110A>T (p.Pro370=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003741998] | ChrX:48904799 [GRCh38] ChrX:48762076 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.91+18A>G | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003740750] | ChrX:48911528 [GRCh38] ChrX:48768805 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.91+15_91+16insT | insertion | SLC35A2-congenital disorder of glycosylation [RCV003740751] | ChrX:48911530..48911531 [GRCh38] ChrX:48768807..48768808 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.99G>A (p.Arg33=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003581415] | ChrX:48909989 [GRCh38] ChrX:48767266 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.426+12G>A | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003740834] | ChrX:48906380 [GRCh38] ChrX:48763657 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.923C>T (p.Ser308Phe) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003740887] | ChrX:48904986 [GRCh38] ChrX:48762263 [GRCh37] ChrX:Xp11.23 |
pathogenic |
NM_005660.3(SLC35A2):c.167_193del (p.Tyr56_Arg64del) | deletion | SLC35A2-congenital disorder of glycosylation [RCV003582886] | ChrX:48909895..48909921 [GRCh38] ChrX:48767172..48767198 [GRCh37] ChrX:Xp11.23 |
likely pathogenic |
NM_005660.3(SLC35A2):c.702C>T (p.Arg234=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003742169]|not provided [RCV003885362] | ChrX:48905207 [GRCh38] ChrX:48762484 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.759T>A (p.Ala253=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003742301] | ChrX:48905150 [GRCh38] ChrX:48762427 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.267G>A (p.Gln89=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003742591] | ChrX:48909821 [GRCh38] ChrX:48767098 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.819C>G (p.Gly273=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003582904] | ChrX:48905090 [GRCh38] ChrX:48762367 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.292G>A (p.Val98Ile) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003740932] | ChrX:48906526 [GRCh38] ChrX:48763803 [GRCh37] ChrX:Xp11.23 |
benign |
NM_005660.3(SLC35A2):c.905C>T (p.Ser302Phe) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003741688] | ChrX:48905004 [GRCh38] ChrX:48762281 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.231C>T (p.Leu77=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003741036] | ChrX:48909857 [GRCh38] ChrX:48767134 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1070G>C (p.Gly357Ala) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003811844] | ChrX:48904839 [GRCh38] ChrX:48762116 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.718C>T (p.Leu240Phe) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003582054] | ChrX:48905191 [GRCh38] ChrX:48762468 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.618C>T (p.Val206=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003582810] | ChrX:48905291 [GRCh38] ChrX:48762568 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1163+16G>T | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003740907] | ChrX:48904730 [GRCh38] ChrX:48762007 [GRCh37] ChrX:Xp11.23 |
benign |
NM_005660.3(SLC35A2):c.191G>A (p.Arg64His) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003741085] | ChrX:48909897 [GRCh38] ChrX:48767174 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.427-13G>A | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003581156] | ChrX:48905495 [GRCh38] ChrX:48762772 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.1090C>T (p.Pro364Ser) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003741426] | ChrX:48904819 [GRCh38] ChrX:48762096 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.945C>T (p.Leu315=) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003740765] | ChrX:48904964 [GRCh38] ChrX:48762241 [GRCh37] ChrX:Xp11.23 |
likely benign |
GRCh37/hg19 Xp22.33-11.1(chrX:168546-58364114) | copy number loss | not specified [RCV003986240] | ChrX:168546..58364114 [GRCh37] ChrX:Xp22.33-11.1 |
pathogenic |
NM_005660.3(SLC35A2):c.1097G>A (p.Gly366Glu) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003859483] | ChrX:48904812 [GRCh38] ChrX:48762089 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
GRCh37/hg19 Xp22.33-11.21(chrX:168546-55653170) | copy number loss | not specified [RCV003986200] | ChrX:168546..55653170 [GRCh37] ChrX:Xp22.33-11.21 |
pathogenic |
NM_005660.3(SLC35A2):c.92-290G>A | single nucleotide variant | SLC35A2-related condition [RCV003911864] | ChrX:48910286 [GRCh38] ChrX:48767563 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_001282648.2(SLC35A2):c.6G>T (p.Lys2Asn) | single nucleotide variant | SLC35A2-related condition [RCV003921773] | ChrX:48911872 [GRCh38] ChrX:48769149 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.918_929dup (p.Val310_Ala311insLeuSerThrVal) | duplication | SLC35A2-congenital disorder of glycosylation [RCV003885329] | ChrX:48904979..48904980 [GRCh38] ChrX:48762256..48762257 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.92-233G>A | single nucleotide variant | SLC35A2-related condition [RCV003924472] | ChrX:48910229 [GRCh38] ChrX:48767506 [GRCh37] ChrX:Xp11.23 |
likely benign |
NM_005660.3(SLC35A2):c.998G>A (p.Gly333Asp) | single nucleotide variant | SLC35A2-congenital disorder of glycosylation [RCV003988704] | ChrX:48904911 [GRCh38] ChrX:48762188 [GRCh37] ChrX:Xp11.23 |
uncertain significance |
NM_005660.3(SLC35A2):c.426+74G>A | single nucleotide variant | not specified [RCV003988544] | ChrX:48906318 [GRCh38] ChrX:48763595 [GRCh37] ChrX:Xp11.23 |
likely benign |
The detailed report is available here: | Full Report | CSV | TAB | Printer | ||||
miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/). For more information about miRGate, see PMID:25858286 or access the full paper here. |
RH78860 |
|
|||||||||||||||||||||||||||||||||||||||||||||
STS-H88980 |
|
|||||||||||||||||||||||||||||||||||||||||||||
STS-R01143 |
|
|||||||||||||||||||||||||||||||||||||||||||||
WI-13527 |
|
alimentary part of gastrointestinal system | circulatory system | endocrine system | exocrine system | hemolymphoid system | hepatobiliary system | integumental system | musculoskeletal system | nervous system | renal system | reproductive system | respiratory system | sensory system | visual system | adipose tissue | appendage | entire extraembryonic component | pharyngeal arch | |
High | 1 | |||||||||||||||||
Medium | 830 | 665 | 1414 | 405 | 1061 | 254 | 2425 | 132 | 1175 | 336 | 816 | 1509 | 167 | 1 | 384 | 1389 | 5 | 2 |
Low | 1609 | 2324 | 312 | 219 | 889 | 211 | 1932 | 2064 | 2559 | 83 | 643 | 104 | 8 | 820 | 1399 | 1 | ||
Below cutoff | 2 | 1 | 1 |
RefSeq Transcripts | NG_034300 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
NM_001032289 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001042498 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001282647 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001282648 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001282649 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001282650 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_001282651 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
NM_005660 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
GenBank Nucleotide | AB042425 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
AC233300 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AF207550 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AI632201 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK090730 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK225508 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK290284 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK292816 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK293415 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK293419 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK298484 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AK299748 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
AL556714 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BC035747 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
BI820134 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CH471224 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CP068255 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
CR450287 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
D84454 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles | |
D88146 | (Get FASTA) | NCBI Sequence Viewer | Search GEO for Microarray Profiles |
RefSeq Acc Id: | ENST00000247138 ⟹ ENSP00000247138 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000376512 ⟹ ENSP00000365695 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000376515 ⟹ ENSP00000365698 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000376521 ⟹ ENSP00000365704 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000376529 ⟹ ENSP00000365712 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000413561 ⟹ ENSP00000393233 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000445167 ⟹ ENSP00000402726 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000446885 ⟹ ENSP00000415518 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000452555 ⟹ ENSP00000416002 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000616181 ⟹ ENSP00000478617 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000634461 ⟹ ENSP00000489440 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000634665 ⟹ ENSP00000489356 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000635015 ⟹ ENSP00000489089 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000635238 ⟹ ENSP00000489515 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000635285 ⟹ ENSP00000489484 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000635460 ⟹ ENSP00000489339 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000635589 ⟹ ENSP00000489197 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | ENST00000635628 ⟹ ENSP00000489613 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | NM_001032289 ⟹ NP_001027460 | ||||||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NM_001042498 ⟹ NP_001035963 | ||||||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NM_001282647 ⟹ NP_001269576 | ||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||
Position: |
|
||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NM_001282648 ⟹ NP_001269577 | ||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||
Position: |
|
||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NM_001282649 ⟹ NP_001269578 | ||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||
Position: |
|
||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NM_001282650 ⟹ NP_001269579 | ||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||
Position: |
|
||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NM_001282651 ⟹ NP_001269580 | ||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||
Position: |
|
||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | NM_005660 ⟹ NP_005651 | ||||||||||||||||||||||||||||||||
RefSeq Status: | REVIEWED | ||||||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||||||
Sequence: |
Protein RefSeqs | NP_001027460 | (Get FASTA) | NCBI Sequence Viewer |
NP_001035963 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001269576 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001269577 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001269578 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001269579 | (Get FASTA) | NCBI Sequence Viewer | |
NP_001269580 | (Get FASTA) | NCBI Sequence Viewer | |
NP_005651 | (Get FASTA) | NCBI Sequence Viewer | |
GenBank Protein | AAH35747 | (Get FASTA) | NCBI Sequence Viewer |
BAA12673 | (Get FASTA) | NCBI Sequence Viewer | |
BAA13545 | (Get FASTA) | NCBI Sequence Viewer | |
BAA95614 | (Get FASTA) | NCBI Sequence Viewer | |
BAA95615 | (Get FASTA) | NCBI Sequence Viewer | |
BAC03509 | (Get FASTA) | NCBI Sequence Viewer | |
BAF82973 | (Get FASTA) | NCBI Sequence Viewer | |
BAF85505 | (Get FASTA) | NCBI Sequence Viewer | |
BAG56922 | (Get FASTA) | NCBI Sequence Viewer | |
BAG56926 | (Get FASTA) | NCBI Sequence Viewer | |
BAG60694 | (Get FASTA) | NCBI Sequence Viewer | |
BAG61639 | (Get FASTA) | NCBI Sequence Viewer | |
CAG29283 | (Get FASTA) | NCBI Sequence Viewer | |
EAW50731 | (Get FASTA) | NCBI Sequence Viewer | |
EAW50732 | (Get FASTA) | NCBI Sequence Viewer | |
EAW50733 | (Get FASTA) | NCBI Sequence Viewer | |
EAW50734 | (Get FASTA) | NCBI Sequence Viewer | |
Ensembl Protein | ENSP00000247138 | ||
ENSP00000247138.5 | |||
ENSP00000365695.1 | |||
ENSP00000365698 | |||
ENSP00000365698.3 | |||
ENSP00000365704 | |||
ENSP00000365704.1 | |||
ENSP00000365712 | |||
ENSP00000365712.3 | |||
ENSP00000393233.3 | |||
ENSP00000402726 | |||
ENSP00000402726.2 | |||
ENSP00000415518.1 | |||
ENSP00000416002 | |||
ENSP00000416002.2 | |||
ENSP00000478617 | |||
ENSP00000478617.1 | |||
ENSP00000489089.1 | |||
ENSP00000489197 | |||
ENSP00000489197.1 | |||
ENSP00000489339.1 | |||
ENSP00000489356.1 | |||
ENSP00000489440.1 | |||
ENSP00000489484.1 | |||
ENSP00000489515.1 | |||
ENSP00000489613.1 | |||
ENSP00000518018.1 | |||
ENSP00000518019.1 | |||
ENSP00000518023.1 | |||
ENSP00000518024.1 | |||
ENSP00000518027.1 | |||
ENSP00000518029.1 | |||
GenBank Protein | P78381 | (Get FASTA) | NCBI Sequence Viewer |
RefSeq Acc Id: | NP_005651 ⟸ NM_005660 |
- Peptide Label: | isoform a |
- UniProtKB: | Q8IV21 (UniProtKB/Swiss-Prot), E7EW45 (UniProtKB/Swiss-Prot), B4DPT2 (UniProtKB/Swiss-Prot), B4DE11 (UniProtKB/Swiss-Prot), A8K9V1 (UniProtKB/Swiss-Prot), A8K2L9 (UniProtKB/Swiss-Prot), Q92553 (UniProtKB/Swiss-Prot), P78381 (UniProtKB/Swiss-Prot), Q6ICV6 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | NP_001035963 ⟸ NM_001042498 |
- Peptide Label: | isoform c |
- UniProtKB: | Q6ICV6 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | NP_001027460 ⟸ NM_001032289 |
- Peptide Label: | isoform b |
- UniProtKB: | P78381 (UniProtKB/Swiss-Prot) |
- Sequence: |
RefSeq Acc Id: | NP_001269576 ⟸ NM_001282647 |
- Peptide Label: | isoform d |
- UniProtKB: | A6NFI1 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | NP_001269577 ⟸ NM_001282648 |
- Peptide Label: | isoform e |
- UniProtKB: | A6NKM8 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | NP_001269578 ⟸ NM_001282649 |
- Peptide Label: | isoform f |
- UniProtKB: | Q6ICV6 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | NP_001269580 ⟸ NM_001282651 |
- Peptide Label: | isoform h |
- UniProtKB: | Q6ICV6 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | NP_001269579 ⟸ NM_001282650 |
- Peptide Label: | isoform g |
- UniProtKB: | B4DE15 (UniProtKB/TrEMBL), Q6ICV6 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | ENSP00000489440 ⟸ ENST00000634461 |
RefSeq Acc Id: | ENSP00000489356 ⟸ ENST00000634665 |
RefSeq Acc Id: | ENSP00000489515 ⟸ ENST00000635238 |
RefSeq Acc Id: | ENSP00000489484 ⟸ ENST00000635285 |
RefSeq Acc Id: | ENSP00000489089 ⟸ ENST00000635015 |
RefSeq Acc Id: | ENSP00000489613 ⟸ ENST00000635628 |
RefSeq Acc Id: | ENSP00000489197 ⟸ ENST00000635589 |
RefSeq Acc Id: | ENSP00000489339 ⟸ ENST00000635460 |
RefSeq Acc Id: | ENSP00000416002 ⟸ ENST00000452555 |
RefSeq Acc Id: | ENSP00000393233 ⟸ ENST00000413561 |
RefSeq Acc Id: | ENSP00000365695 ⟸ ENST00000376512 |
RefSeq Acc Id: | ENSP00000365698 ⟸ ENST00000376515 |
RefSeq Acc Id: | ENSP00000365704 ⟸ ENST00000376521 |
RefSeq Acc Id: | ENSP00000365712 ⟸ ENST00000376529 |
RefSeq Acc Id: | ENSP00000247138 ⟸ ENST00000247138 |
RefSeq Acc Id: | ENSP00000478617 ⟸ ENST00000616181 |
RefSeq Acc Id: | ENSP00000402726 ⟸ ENST00000445167 |
RefSeq Acc Id: | ENSP00000415518 ⟸ ENST00000446885 |
Name | Modeler | Protein Id | AA Range | Protein Structure |
AF-P78381-F1-model_v2 | AlphaFold | P78381 | 1-396 | view protein structure |
RGD ID: | 6809270 | ||||||||
Promoter ID: | HG_KWN:66714 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell, CD4+TCell_2Hour, HeLa_S3, K562, Lymphoblastoid | ||||||||
Transcripts: | UC004DLR.1 | ||||||||
Position: |
|
RGD ID: | 6808694 | ||||||||
Promoter ID: | HG_KWN:66715 | ||||||||
Type: | CpG-Island | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | MPROMDB | ||||||||
Tissues & Cell Lines: | CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4 | ||||||||
Transcripts: | ENST00000376512, ENST00000376515, ENST00000376529, NM_001042498, OTTHUMT00000060794, UC004DLO.1, UC004DLQ.1 | ||||||||
Position: |
|
RGD ID: | 6851360 | ||||||||
Promoter ID: | EP73478 | ||||||||
Type: | single initiation site | ||||||||
Name: | HS_SLC35A2 | ||||||||
Description: | Solute carrier family 35 (UDP-galactose transporter), member 2. | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPD (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Experiment Methods: | NEDO full length human cDNA sequencing project.; Oligo-capping | ||||||||
Position: |
|
RGD ID: | 13605256 | ||||||||
Promoter ID: | EPDNEW_H28812 | ||||||||
Type: | initiation region | ||||||||
Name: | SLC35A2_1 | ||||||||
Description: | solute carrier family 35 member A2 | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Alternative Promoters: | null; see alsoEPDNEW_H28813 | ||||||||
Experiment Methods: | Single-end sequencing. | ||||||||
Position: |
|
RGD ID: | 13605258 | ||||||||
Promoter ID: | EPDNEW_H28813 | ||||||||
Type: | initiation region | ||||||||
Name: | SLC35A2_2 | ||||||||
Description: | solute carrier family 35 member A2 | ||||||||
SO ACC ID: | SO:0000170 | ||||||||
Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||
Alternative Promoters: | null; see alsoEPDNEW_H28812 | ||||||||
Experiment Methods: | Single-end sequencing. | ||||||||
Position: |
|
Database | Acc Id | Source(s) |
AGR Gene | HGNC:11022 | AgrOrtholog |
COSMIC | SLC35A2 | COSMIC |
Ensembl Genes | ENSG00000102100 | Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
ENSG00000292209 | UniProtKB/Swiss-Prot | |
Ensembl Transcript | ENST00000247138 | ENTREZGENE |
ENST00000247138.11 | UniProtKB/Swiss-Prot | |
ENST00000376512.2 | UniProtKB/TrEMBL | |
ENST00000376515 | ENTREZGENE | |
ENST00000376515.8 | UniProtKB/TrEMBL | |
ENST00000376521 | ENTREZGENE | |
ENST00000376521.6 | UniProtKB/Swiss-Prot | |
ENST00000376529 | ENTREZGENE | |
ENST00000376529.8 | UniProtKB/TrEMBL | |
ENST00000413561.7 | UniProtKB/TrEMBL | |
ENST00000445167 | ENTREZGENE | |
ENST00000445167.7 | UniProtKB/Swiss-Prot | |
ENST00000446885.1 | UniProtKB/TrEMBL | |
ENST00000452555 | ENTREZGENE | |
ENST00000452555.7 | UniProtKB/Swiss-Prot | |
ENST00000616181 | ENTREZGENE | |
ENST00000616181.5 | UniProtKB/TrEMBL | |
ENST00000634461.1 | UniProtKB/TrEMBL | |
ENST00000634665.1 | UniProtKB/TrEMBL | |
ENST00000635015.1 | UniProtKB/TrEMBL | |
ENST00000635238.1 | UniProtKB/TrEMBL | |
ENST00000635285.1 | UniProtKB/Swiss-Prot | |
ENST00000635460.1 | UniProtKB/TrEMBL | |
ENST00000635589 | ENTREZGENE | |
ENST00000635589.1 | UniProtKB/Swiss-Prot | |
ENST00000635628.1 | UniProtKB/TrEMBL | |
ENST00000710051.1 | UniProtKB/Swiss-Prot | |
ENST00000710052.1 | UniProtKB/Swiss-Prot | |
ENST00000710056.1 | UniProtKB/Swiss-Prot | |
ENST00000710057.1 | UniProtKB/Swiss-Prot | |
ENST00000710060.1 | UniProtKB/Swiss-Prot | |
ENST00000710062.1 | UniProtKB/Swiss-Prot | |
Gene3D-CATH | 1.10.3730.20 | UniProtKB/TrEMBL |
GTEx | ENSG00000102100 | GTEx |
ENSG00000292209 | GTEx | |
HGNC ID | HGNC:11022 | ENTREZGENE |
Human Proteome Map | SLC35A2 | Human Proteome Map |
InterPro | Nuc_sug_transpt | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
KEGG Report | hsa:7355 | UniProtKB/Swiss-Prot |
NCBI Gene | 7355 | ENTREZGENE |
OMIM | 314375 | OMIM |
PANTHER | PTHR10231 | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
UDP-GALACTOSE TRANSLOCATOR | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL | |
Pfam | Nuc_sug_transp | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
PharmGKB | PA35890 | PharmGKB, RGD |
PIRSF | UDP-gal_transpt | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
Superfamily-SCOP | Multidrug resistance efflux transporter EmrE | UniProtKB/Swiss-Prot, UniProtKB/TrEMBL |
UniProt | A0A0U1RR48_HUMAN | UniProtKB/TrEMBL |
A0A0U1RR61_HUMAN | UniProtKB/TrEMBL | |
A0A0U1RRB4_HUMAN | UniProtKB/TrEMBL | |
A0A0U1RRG4_HUMAN | UniProtKB/TrEMBL | |
A0A0U1RRN1_HUMAN | UniProtKB/TrEMBL | |
A0A0X1KG77_HUMAN | UniProtKB/TrEMBL | |
A6NFI1 | ENTREZGENE, UniProtKB/TrEMBL | |
A6NGW4_HUMAN | UniProtKB/TrEMBL | |
A6NKM8 | ENTREZGENE, UniProtKB/TrEMBL | |
A8K2L9 | ENTREZGENE | |
A8K9V1 | ENTREZGENE | |
B4DE11 | ENTREZGENE | |
B4DE15 | ENTREZGENE, UniProtKB/TrEMBL | |
B4DPT2 | ENTREZGENE | |
B4DSH7_HUMAN | UniProtKB/TrEMBL | |
C9JCV5_HUMAN | UniProtKB/TrEMBL | |
E7EW45 | ENTREZGENE | |
P78381 | ENTREZGENE | |
Q6ICV6 | ENTREZGENE, UniProtKB/TrEMBL | |
Q8IV21 | ENTREZGENE | |
Q92553 | ENTREZGENE | |
S35A2_HUMAN | UniProtKB/Swiss-Prot | |
UniProt Secondary | A8K2L9 | UniProtKB/Swiss-Prot |
A8K9V1 | UniProtKB/Swiss-Prot | |
B4DE11 | UniProtKB/Swiss-Prot | |
B4DPT2 | UniProtKB/Swiss-Prot | |
E7EW45 | UniProtKB/Swiss-Prot | |
Q8IV21 | UniProtKB/Swiss-Prot | |
Q92553 | UniProtKB/Swiss-Prot |
Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
---|---|---|---|---|---|---|---|
2016-03-08 | SLC35A2 | solute carrier family 35 member A2 | solute carrier family 35 (UDP-galactose transporter), member A2 | Symbol and/or name change | 5135510 | APPROVED |